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Abstract
Startling advances in biological gerontology coupled with the ongoing, global demographic transition to
older populations have intensified humankind’s ancient quest to understand the nature of aging. This
dissertation explores mechanisms of mortality through the prism of immunology. To effect defense
against pathogens both exogenous and endogenous, the adaptive immune system leverages the
tremendous proliferative capacity with which it is endowed to generate terminally differentiated
lymphocytes that potently eliminate or suppress threats to organismal health. This proliferative capacity
derives from the integrity of genomically encoded information, and, while considerable, is not infinite: it
can be depleted with age and following repeated rounds of antigen-driven proliferation, for example, when
driven by recurring or persisting microbial infections, or cancer. In the studies detailed herein, genome
integrity homeostasis was probed during the immune response to viral infection. CD8+ T cells were
observed to experience significant DNA damage in the course of their attempts to control viral replication.
Multiparametric flow cytometry identified a rare population of antigen-specific T stem cells that might
represent an evolutionary strategy to minimize genotoxicity. The programming, metabolic profile,
anatomic localization, proliferative capacity, and ontogeny of these T stem cells were analyzed in relation
to previously established effector, memory precursor, and central memory populations. Developmentally,
T stem cells were able to self-renew and both give rise to abundant cytotoxic effector CD8+ T cells in the
presence of antigen as well as contribute to the pool of long-term central memory CD8+ T cells following
antigen clearance. Remarkably, partially-differentiated transit-amplifying effector CD8+ T cells also
contributed to long-term central memory, in a process of apparent dedifferentiation. Programmatically, T
stem cells were endowed with superior expression of multiple genome maintenance and repair activities,
including heightened responsiveness to DNA strand breaks, telomerase expression, and suppression of
potentially mutagenic transposition by the ancient LINE-1 retrotransposon. Together, these features
suggest that this characteristic of amplified genome integrity surveillance may be a fundamental feature
of somatic stem cells broadly, and important for the long-term maintenance of antigen-experienced T cell
populations in particular. Additionally, despite relative proliferative quiescence, T stem cells unexpectedly
manifested intense signaling flux. This was associated with robust expression of a panoply of both
stimulatory and inhibitory cell surface receptors, including PD-1. Intensified signaling consequent to
genetic ablation of inhibitory receptors compromised T stem cell viability during acutely-resolving viral
infections. These findings hold significant implications for basic understanding of pathogen-driven
peripheral T cell differentiation, formation of long-term immunological memory, and aging; and for the
design of therapeutic, prophylactic, and diagnostic applications intended to further the cause of
maximizing healthy human lifespan.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Biology

First Advisor
Edward J. Wherry

Keywords
aging, cancer, genome integrity, immunological memory, stem cells, T cells

Subject Categories
Allergy and Immunology | Biology | Family, Life Course, and Society | Immunology and Infectious Disease |
Medical Immunology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2371

DEDIFFERENTIATION OF CYTOTOXIC LYMPHOCYTES
INTO CENTRAL MEMORY CD8+ T CELLS:
LESSONS FROM ANTIVIRAL T STEM CELLS ON THE
ARCHITECTURE OF AGING & IMMUNOTHERAPY
Jonathan Basil Johnnidis
A DISSERTATION
in
Biology
Presented to the Faculties of the University of Pennsylvania
in Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2017

Supervisor of Dissertation
_______________________
E. John Wherry, Ph.D., Professor of Microbiology

Graduate Group Chairperson
_______________________
Michael A. Lampson, Ph.D., Associate Professor of Biology

Dissertation Committee
David S. Roos, Ph.D., Professor of Biology
Shelley L. Berger, Ph.D., University Professor
Brian D. Gregory, Ph.D., Associate Professor of Biology
F. Brad Johnson, M.D., Ph.D., Associate Professor of Pathology

DEDIFFERENTIATION OF CYTOTOXIC LYMPHOCYTES INTO CENTRAL
MEMORY CD8+ T CELLS: LESSONS FROM ANTIVIRAL T STEM CELLS ON
THE ARCHITECTURE OF AGING & IMMUNOTHERAPY
COPYRIGHT
2017
Jonathan Basil Johnnidis

ii

ACKNOWLEDGEMENTS
My scientific career formally commenced in a quirky Drosophila genetics
laboratory with a Socratic bang, delivered by way of a prompt I shall never forget,
intoned in an inimitable Swiss-German accent impossible not to notice: “tell-youme-this.” Thusly – with questions instead of answers – did Adrian Rothenfluh
return -- often frustratingly, always fruitfully -- my many adolescent queries about
the nature of biology and research, and thereby prompt me to begin thinking
critically and independently. To him, then himself a graduate student and now a
Professor, I owe a deep debt of gratitude.
Here at the University of Pennsylvania, my journey as an empiricist in training
first and foremost is a function of the tremendous opportunity provided by my
advisor, E. John Wherry, to engage in challenging, important, and rewarding
research. I am grateful to him for the marvelous privilege of scientific pursuit –
and as well for sharing his enthusiasm about the value of exercise and sheer fun
of trail running in particular. David Siker Roos, my thesis committee chair,
offered in abundance his time, insights, and sympathy with a generosity that
betrays the awesome depth of his commitment to teaching and mentorship. I’m
also grateful to David for sharing his taste in West African music, and for his wry
observations about the eccentricities of eminent intellects.
At the bench, many collaborations greatly enriched my immunogerontological
investigations, and my project would have amounted to much less without the
substantial contributions of Travis Doering, Jesse Platt, Sophie Song, Michael
Paley, Pamela Odorizzi, Kristen Pauken, Bertram Bengsch, Shin Foon Ngiow,
and Spyros Stavrou. I thank them for sharing expertise, insight, mice, cells, and
data.
Lastly and most importantly, I acknowledge my family. My godparents gifted me
invaluable perspective on the nature of time and positivity. My siblings and
parents have been along for this weird and wonderful ride from the very
beginning, through thick and thin. Thank you, thank you.

iii

ABSTRACT
DEDIFFERENTIATION OF CYTOTOXIC LYMPHOCYTES
INTO CENTRAL MEMORY CD8+ T CELLS:
LESSONS FROM ANTIVIRAL T STEM CELLS ON THE
ARCHITECTURE OF AGING & IMMUNOTHERAPY
Jonathan B. Johnnidis
E. John Wherry
Startling advances in biological gerontology coupled with the ongoing, global
demographic transition to older populations have intensified humankind’s ancient quest
to understand the nature of aging. This dissertation explores mechanisms of mortality
through the prism of immunology. To effect defense against pathogens both exogenous
and endogenous, the adaptive immune system leverages the tremendous proliferative
capacity with which it is endowed to generate terminally differentiated lymphocytes that
potently eliminate or suppress threats to organismal health. This proliferative capacity
derives from the integrity of genomically encoded information, and, while considerable, is
not infinite: it can be depleted with age and following repeated rounds of antigen-driven
proliferation, for example, when driven by recurring or persisting microbial infections, or
cancer. In the studies detailed herein, genome integrity homeostasis was probed during
the immune response to viral infection. CD8+ T cells were observed to experience
significant DNA damage in the course of their attempts to control viral replication.
Multiparametric flow cytometry identified a rare population of antigen-specific T stem
cells that might represent an evolutionary strategy to minimize genotoxicity. The
programming, metabolic profile, anatomic localization, proliferative capacity, and
ontogeny of these T stem cells were analyzed in relation to previously established
effector, memory precursor, and central memory populations. Developmentally, T stem
cells were able to self-renew and both give rise to abundant cytotoxic effector CD8+ T
cells in the presence of antigen as well as contribute to the pool of long-term central
memory CD8+ T cells following antigen clearance. Remarkably, partially-differentiated
transit-amplifying effector CD8+ T cells also contributed to long-term central memory, in
a process of apparent dedifferentiation. Programmatically, T stem cells were endowed
with superior expression of multiple genome maintenance and repair activities, including
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heightened responsiveness to DNA strand breaks, telomerase expression, and
suppression of potentially mutagenic transposition by the ancient LINE-1
retrotransposon. Together, these features suggest that this characteristic of amplified
genome integrity surveillance may be a fundamental feature of somatic stem cells
broadly, and important for the long-term maintenance of antigen-experienced T cell
populations in particular. Additionally, despite relative proliferative quiescence, T stem
cells unexpectedly manifested intense signaling flux. This was associated with robust
expression of a panoply of both stimulatory and inhibitory cell surface receptors,
including PD-1. Intensified signaling consequent to genetic ablation of inhibitory
receptors compromised T stem cell viability during acutely-resolving viral infections.
These findings hold significant implications for basic understanding of pathogen-driven
peripheral T cell differentiation, formation of long-term immunological memory, and
aging; and for the design of therapeutic, prophylactic, and diagnostic applications
intended to further the cause of maximizing healthy human lifespan.
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.:: CHAPTER 1 ::.
AGING, IMMUNOLOGICAL MEMORY, AND THE GENOME
INTEGRITY PARADOX OF T CELL CLONAL EXPANSION
1.1 Aging is of ancient and central concern to the human condition
“Our new Constitution is now established, and has an appearance that promises
permanency; but in this world nothing can be said to be certain, except death and
taxes.”
- Benjamin Franklin, 1789
Writing in a period of transition and intense uncertainty – shortly before his own
death, and on the occasion of the birth of a new nation – Benjamin Franklin
opined on the few constants that figure in life. While the subject of taxation lies
beyond the scope of inquiry in this work, death lies at its center. Indeed,
mortality and the universal process of aging that inevitably precipitates it have
invited curiosity and concern throughout the history of humankind. The very birth
of literature some four thousand years ago – in the Sumerian epic of Gilgamesh
– centered upon the pain of death and a quest for immortality. In the present
day, ongoing demographic transitions in industrially developed and developing
nations have heightened attention to the issue of graying populations (Olshansky
et al., 1990; Vaupel, 2010; Olshansky, 2016). At the beginning of the present
decade, 13-22% of European, American, and Chinese populations exceeded 60
years of age, and this figure is projected to rise to 27-34% by 2050. Globally,
there will be more than two billion people 60 years of age or older by 2050, by
which point this class of older individuals will outnumber the population of
children (0-14 years of age) for the first time in human history (United Nations
1

Department of Economic and Social Affairs Population Division, 2012). These
trends pose tremendous challenges at every level of social organization,
including the maintenance of health and care for the ill. Beyond any particular
physiological, lifestyle, or environmental parameter, age itself is the single
greatest risk factor for the pathologies that inflict the largest burden of morbidity
and mortality, including cardiovascular disease, cancer, and neurodegenerative
conditions (Marrero et al., 2012; Kohanski, 2016). This begs the question of
whether the aging process can be sufficiently understood in order to enable
interventions that might potentiate healthier and perhaps longer life trajectories.

1.2 History and universality of mortality
While the question of aging has been mooted for millennia, extensively explored
by titans of literature, and even empirically pursued by notables ranging from
ancient Chinese emperors to Isaac Newton, only since the birth of cell theory in
the mid 19th century has it become experimentally tractable. Building on
microscopic observations from Theodor Schwann and Robert Remak, the
pioneering physician, pathologist, and public health visionary Rudolph Virchow
famously declared that “omnis cellula e cellula” (Virchow, 1855) – all cells are
derived by way of genesis from pre-existing cells, not begotten from some
amorphous, inanimate source. This signal insight in turn opened the door for
aging to be examined and potentially understood for the first time in terms of an
observable, tangible, quantity – cells.
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The dawn of the modern study of aging had to await the ability to study
live, actively metabolizing cells as opposed to chemically preserved specimens.
This moment arrived a half century later with the advent of ex vivo tissue culture.
In the 19-teens, just a few months before he was awarded the Nobel prize that
cemented his outsized public stature and further amplified the authority of his
biomedical pronouncements, Alexis Carrel of the Rockefeller Institute initiated an
elaborate, decades-long series of experiments involving culture of chicken cells.
He put fresh cells into culture flasks, and as long as the nutrient medium was
regularly replenished, he observed that the cells appeared to persist, metabolize,
and divide without end. Carrel, his colleagues, and an enthralled public
interpreted this seemingly ceaseless vitality as being consistent with biological
immortality (Shay and Wright, 2000). At the cellular level at least, they believed,
death need not be foreordained. Though some in the scientific community
doubted this conclusion and the strength of the data that supported it, this
interpretation reigned as dogma for the better part of the next 50 years.
Not more than several dozen paces from where these words are being
written, Leonard Hayflick and his colleagues turned this notion on its head
starting in the early 1960's in Philadelphia. In careful culture experiments with
primary human fibroblasts, they observed that non-transformed cells consistently
ceased replicating after 40-50 divisions (Hayflick and Moorhead, 1961). With the
notable exception of genetically unstable cancer cells, physiologically normal
cells in culture appeared to be possessed not of unbounded but rather finite
replicative potential. This observation, later termed replicative senescence or the
3

“Hayflick limit” by the immunologist Macfarlane Burnet (Burnet, 1974), is thought
to represent a cellular model of organismal aging, as mutations in many genes
that accelerate its onset also cause premature aging in animal models and
humans (Lombard et al., 2005). The paradigm of senescence has been
extended both in vitro to dozens of additional cell types and in vivo across
multiple organisms (Herbig et al., 2006; Baker et al., 2011), even including
prokaryotes (Ackermann et al., 2003; Stewart et al., 2005), which until recently
were believed to represent a key deviation from Hayflick's paradigm
(Charlesworth, 2000). Though there may be an intriguing exception in the case
of hydra (Boehm et al., 2012), Hayflick’s fundamental insight into the lives of cells
remains a pillar of modern biological inquiry – in short, the lease on life for any
given cells and the organism they comprise is definite; everything must die.

1.3 A central role for the immune system in systemic aging
If death is inevitable, what then is the mechanism of mortality? In the late 19th
century the German developmental biologist August Weismann speculated that
“death takes place because a worn-out tissue cannot forever renew itself”
(Weismann, 1889). Since then numerous observations and mechanistic
explanations have emerged, with most amounting to a time-dependent
accumulation of various types of cellular damage, including especially to the
genome and the epigenome (Lopez-Otin et al., 2013; Vijg, 2014), and regulation
of lifespan by genetic modulation of the net rate of damage accumulation
(Burnet, 1973; Gladyshev, 2012). However, how indeterminate deficiencies at
4

the cellular level manifest in the organism-scale loss of functionality and fecundity
that define aging remains incompletely understood, and is currently the subject of
exceptionally vigorous investigation across multiple disciplines. Not long after
Hayflick’s revelation, and building on earlier work by Burnet concerning somatic
mutation rates in the immune system and age-dependent autoimmunity (Burnet,
1959), the gerontologist Roy Walford proposed that of all the separate and
complex tissues that together comprise the mammalian body plan, the
interlocking assemblage of leukocytes commonly referred to as the “immune
system” might be particularly central to overall organismal aging (Walford, 1969).
Developed extensively over the course of the next several decades, this notion
that systemic aging is a function of pathological immune processes has been
borne out by several complementary lines of evidence.
First among these are multiplying observations that many of the most
salient infirmities of aging are accompanied by dysregulated immune function, for
example in the cases of atherosclerosis, wherein senescent macrophages
accumulate in subendothelial spaces and drive atheroma formation (Childs et al.,
2016); in neurocognitive degeneration, wherein T cell deficiency has been shown
to diminish the adult hippocampal neurogenesis (Huang et al., 2010) thought to
underlie substantial aspects of learning, memory, and emotional regulation
(Eriksson et al., 1998; Spalding et al., 2013); and perhaps most intriguingly in
cancer, wherein benign tumors may exploit age-diminished adaptive
immunosurveillance to embark on the transformation to clinically-evident
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malignancy (Cheney and Walford, 1974; Miller, 1996; Castro et al., 2009;
Pawelec et al., 2009; Malaguarnera et al., 2010; Chou and Effros, 2013).
Even more saliently than associations with chronic ailments however,
immune function in the elderly is often linked to substantially decreased
functionality with respect to its most familiar role, that of pathogen defense. This
nearly universal time-acquired immunodeficiency syndrome limits the protections
of vaccination and engenders susceptibility to a panoply of communicable
diseases, including most prominently influenza, herpes zoster, urinary tract
infections, infective endocartitis, bacterial meningitis, and nosocomial infections
generally (Gavazzi and Krause, 2002). Importantly, infectious diseases in the
aged are both more frequent and more severe, resulting in increased demand for
clinical services and increased mortality (Gavazzi and Krause, 2002).
While age-associated immunodeficiency can clearly herald death by
infection, an inverse correlation has also been documented, in that more robust
immune status characterizes those who survive into the ninth, tenth, or even
eleventh decade of life (Strindhall et al., 2007; Sansoni et al., 2008;
Derhovanessian et al., 2010). Longevity associated with increased resistance to
infection has also been documented in mutants of the roundworm Caenorhabditis
elegans (Garsin et al., 2003), suggesting the possibility of an evolutionarilyconserved relationship between immunity and organismal aging.

6

1.4 History of immunity
If declining immune function at least in part precipitates overall, organismal
aging, what is it that drives senescence in the immune system in the first place,
and why might that process proceed briskly in some individuals and more
conservatively others? This dissertation attempts to provide a biological
framework within which to address these vital questions and discuss their
implications.
A reasonable point at which to start dissecting the terminus of immunity is
the beginning of its understanding, which coincidentally corresponds to the birth
of modern history 2500 years ago in the form of an Athenian general’s
unprecedented chronicle of the three decades’ civil war that lead to the
disintegration of an empire and the collapse of humanity’s first experiment in
democracy. In his sweeping History of the Peloponnesian War, Thucydides
described the social and psychological stresses of repeated sieges, and
documented the infectious disease outbreaks that terrorized the densely-packed
citizens of Athens even more so than sightings of advancing Spartan phalanxes.
Himself a survivor of the devastating 430 BC Plague of Athens that claimed at
least a full third the population, Thucydides recounted the thoroughly
indiscriminate nature of the “pestilential disorder” that afflicted commoners and
elites alike, causing all those affected to “drop like sheep.” Importantly, while
Athenian society as a whole was devastated by contagion, some individuals
recovered after having been stricken. Indeed, Thucydides recorded that
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“though many lay unburied, birds and beasts would not touch them, or
died after tasting them… The bodies of dying men lay one upon the
other… [But] those who had recovered from the disease… had now no
fear for themselves; for the same man was never attacked twice – at least
never fatally.” (Thucydides, History of the Peloponnesian War, 2.51).
Today, the concept of immunological memory recognized as the hallmark
of the adaptive immune system can be traced to that original observation of
acquired immunity (from the Latin immunitas, for “exemption”) to subsequent
microbial infection (Masopust et al., 2007). Starting 1500 years later in India and
China and up until the 18th century in Europe, and prompted by the emergence of
smallpox as a frequent, major killer in urban centers, deliberate transfer of
pustular fluids from smallpox scabs into the skin of uninfected persons (so called
“variolation”) was practiced in the hope that a slightly milder yet protective
infection might result. Apparently prompted by bucolic folklore, the English
empiricist Edward Jenner is credited with formalizing the notion that inoculation
not with live smallpox but rather with the related agent cowpox (or Variolae
vaccinae as he called it, from the Latin vacca for cow) could offer protection just
as well but without the certain virulence and mortal risk of a full-blown smallpox
infection (Baxby, 1999).
Thereafter, the practice and later the science of “vaccination” (so dubbed
by Louis Pasteur, in recognition of Jenner’s contribution) advanced in earnest,
especially with the advent of germ theory and Pasteur’s development of
reproducible attenuation techniques that for the first time allowed rationally
converting a virulent microbe into a candidate vaccine that could be empirically
tested in animal and human test subjects for the ability to confer protective
8

immunity. Successful rabies and anthrax vaccines ensued, followed in the mid
20th century by effective vaccines for yellow fever (contributed by Max Theiler)
and polio (Jonas Salk). In prodigious feats of biomedical creativity unlikely to be
witnessed again, uber-vaccinologist Maurice Hilleman developed 8 of the 14
vaccines in current vaccine schedules, including those for measles, mumps,
hepatitis A, hepatitis B, chickenpox, meningitis, pneumonia and Haemophilus
influenza. Because of vaccines, the ancient scourge of smallpox has been
eradicated (Foege, 2001), and polio – which once paralyzed half a million
annually (Kew et al., 2005) – as well as measles and tetanus have been
restricted from large swaths of the globe. Lately, newly-introduced vaccines
against rotavirus and HPV, respectively, have substantially reduced the
incidence of severe pediatric gastroenteritis (Parashar et al., 2016) and infection
with the virus responsible for the vast majority of cervical and anogenital cancers
(Markowitz et al., 2016). Most recently, a vaccine against Ebola has been
developed (Henao-Restrepo et al., 2017), and a candidate vaccine against Zika
has demonstrated efficacy in mouse and non-human primate model systems
(Pardi et al., 2017).

1.5 Nature of immunological memory
Underlying all of these collectively stupendous achievements in biomedical and
public health engineering is the capacity of the adaptive immune system to
remember a primary or “priming” infection and exploit the imprint of this
experience to respond with greater force and superior efficiency to any
9

subsequent encounters with the pathogenic agent in question, whether that be a
virus, bacterium, parasite, tumor, or artificially engineered antigen (i.e., a
vaccine). However, though the capacity for remembrance of pathogens past is a
defining feature of all 65,000 extant vertebrate species, and may even have
enabled the Cambrian explosion 500 million years ago (Pancer and Cooper,
2006), the nature of the physiology that underlies it remains incompletely
understood. In particular, while so-called “memory” lymphocytes are recognized
as the repository for immunological experience, and thus the source of recall
ability, their developmental origins are the subject of lively controversy (Ahmed et
al., 2009; Restifo and Gattinoni, 2013) and a longstanding holy grail of
biomedical research (Lefrançois and Masopust, 2009).
Multifarious are the subtypes of lymphocytes thought to mediate
immunological memory, including natural killer cells (Sun et al., 2009), B cells,
and subtypes of T cells (so called because they develop in the thymus) defined
by expression of either the CD4 or CD8 molecules (Ahmed and Gray, 1996). Of
these, T cells are particularly important for the control of tumors, viruses, and
intracellular bacteria, among other pathogens. This insight emerged from
multiple observations of increased susceptibility to infection or tumorigenesis and
more severe pathogenesis in animals (including non-human and human
primates, as well as mice) with congenital or acquired deficiencies in T cells or
genetic factors vital for their function (Kagi et al., 1994; Jin et al., 1999; Stepp et
al., 1999; Koebel et al., 2007).
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Much of the substantial knowledge accumulated about T cell biology has
come from studies with lymphocytic choriomeningitis virus (LCMV), a human
pathogen maintained in a rodent host reservoir that was discovered in 1933 by
Charles Armstrong by way of an encephalitis epidemic in St. Louis (Zhou et al.,
2012). LCMV is a single-stranded RNA virus and archetypal member of the
Arenaviridae family. Its genome consists of two ambisense RNA segments that
encode four proteins. Viral entry is mediated by binding of LCMV’s glycoprotein
to α-dystroglycan, a widely-expressed receptor on host cells that enables an
unusually broad tropism for LCMV and thus multi-organ dissemination (Cao et
al., 1998). Outcomes of infection range from subclinical illness in healthy
individuals to thrombocytopenia and life-threatening encephalitis in
immunocompromised individuals, and severe congenital defects (Fischer et al.,
2006). Infection elicits a vigorous and reproducible immune response in both
rodents and humans (Kotturi et al., 2011) whose resolution is dependent on
CD8+ T cells (Byrne and Oldstone, 1984; Moskophidis et al., 1987). After initial
exposure to viral antigen, a naïve CD8+ T cell specific for the antigen becomes
activated and is caused to initiate a phase of rapid proliferation and differentiation
that spawns abundant clonal descendants over the course of several days or
weeks (Murali-Krishna et al., 1998). To maximize organismal survival and
fitness, most of these progeny cells are robustly endowed with a variety of potent
molecular effector mechanisms that conduce to purging virus from infected cells,
or whole infected cells from the host. For example, a particularly prominent
cytotoxic effector mechanism revolves around the perforin-granzyme pathway
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(Kagi et al., 1994), in which perforin and granzyme proteins are exocytosed from
specialized secretory lysosomes into the cleft formed between the abutting killer
and virally-infected cell membranes. Perforin, a 67-kilodalton protein with an Nterminal membrane-attack-complex domain similar to that of cytolysins in Gram+
bacteria, oligomerizes into 19-24mers to form pores of roughly 150 Å in the target
cell’s plasma membrane (Law et al., 2010). These transiently perturb calcium
flux and inflict osmotic stress, thereby triggering a stereotypical woundedmembrane repair response that in turn enables granzymes to access the target
cell’s cytosol via an endocytic pathway (Law et al., 2010; Thiery et al., 2011).
Once within the target cell, granzymes, a family of pro-apoptotic serine
proteases, cleave a series of substrates in the cytosol, mitochondria, and nucleus
to effect regulated auto-destruction of the cell (as opposed to the disorderly and
inflammatory alternative of necrosis), thereby efficiently removing it as a threat to
the overall health of the host organism (Thiery and Lieberman, 2014). Following
clearance of virus, the vast majority of the cells generated from the founding,
antigen-specific naïve CD8+ T cell are no longer needed and commit to apoptosis
in a process termed contraction (Lau et al., 1994). However, a small percentage
of cells escapes this culling and persists long-term in order to mediate defense
should the pathogen ever be re-encountered (Lau et al., 1994; Kaech and
Wherry, 2007). This population is what are known as memory T cells.
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1.6 Provenance of immunological memory: one burning question and
three clues
While the existence of memory T cells following the resolution of a pathogenic
perturbation is firmly established, and their properties – including lifelong
persistence and vast proliferative capacity upon pathogen re-encounter – have
been examined extensively, the precise sequence of developmental elaborations
that transform an inert, naïve lymphocyte into a hardened, durable, protective
memory T cell is hotly contested (discussed in depth in Chapter 2). In essence,
that which is in question has been termed the “molecular biography” of the cell
(Shaywitz and Melton, 2005): whence memory? Though even a semblance of
consensus on this matter has remained elusive, several crucial clues to memory
T cell provenance have emerged.

1.6.1 T cell proliferative potential is finite
The first clue concerns finitude: a single, activated naïve CD8+ T cell can divide
repeatedly to generate up to 100,000 progeny cells following antigenic
stimulation (Rocha et al.,1989). Following resolution, memory cells derived from
the original cell can execute a similarly expansive feat of multiplication upon
pathogen re-exposure, as can secondary and tertiary memory cells that emerge
following repeated rounds of infection and resolution. Clearly, the proliferative
capacity of T cells is tremendous. However, it is apparently not unbounded.
While some of the early experiments in ex vivo culture appeared to indicate that
human T cells were possessed of unlimited replicative capacity (Morgan et al.,
1976), subsequent analyses revealed these initial interpretations were
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confounded by the presence of pathologically immortalized, transformed cells
(Effros, 2004). Instead, clonal populations of untransformed T cells invariably
ceased proliferating in culture after repeated rounds of mitogenic stimulation
(Effros, 2004). Subsequently, this paradigm was extended to the behavior of T
cells in vivo, wherein clonally-derived T cells were caused to undergo repeated
rounds of infection-driven expansion and contraction in the context of a serial
transplantation scenario that maximized the potential for replicative stress. While
robust during the first three rounds of antigen-driven proliferation, T cell
expansion all but ceased when cells were activated by a fourth infection
(Masopust et al., 2006). Further in vivo studies have noted a strictly inverse
relationship between replicative history and future potential for proliferation
and/or conferring protection from stringent pathogenic challenges (Hinrichs et al.,
2009; Nolz and Harty, 2011; Martin et al., 2012; Fraser et al., 2013, Van
Braeckel-Budimir N et al., 2017).
That T cells can undergo extensive yet ultimately finite rounds of
replication both in vitro and in vivo is highly reminiscent of Hayflick’s seminal
observations of fibroblast senescence. In fact, though quantitating cell division in
vivo is challenging, based on estimates of ~15-20 divisions per round of antigendriven expansion (Murali-Krishna et al., 1998; Kaech et al., 2002; Masopust et
al., 2007), it seems likely that the T cells subjected to the replicative stress of
serial expansion (Masopust et al., 2006) likely underwent a total of 45-60
divisions before exhausting proliferative capacity. This corresponds closely to
the range originally reported for fibroblast senescence (Hayflick, 1965).
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What then might be basis for this vital finitude? In a broader context, this
amounts to a timeless question: what is the biological substrate of aging? In the
case of Hayflickian senescence, decades of inquiry have indicated that
proliferative potential is circumscribed by the accumulation of genomic and
epigenomic damage. One example of this is manifested in the progressive,
division-dependent attrition of telomeres, the nucleoprotein complexes that cap
chromosome ends and thereby preserve genome integrity (discussed in depth in
Chapter 3). While there exists a striking paucity of understanding concerning
genome integrity homeostasis in leukocytes, a preponderance of evidence
indicates that T cell telomeres shorten with progressive proliferation and/or age
(Sallusto et al., 1999; Hodes et al., 2002; Chou et al., 2013). Beyond telomeres,
other forms of genomic insults increase, including chromosomal rearrangements
(Ramsey et al., 1995). Thus, T cell proliferative potential is potent yet limited,
apparently like that of any other cell type, and this finitude corresponds with
decreasing genomic integrity.

1.6.2 Memory T cells are long-lived
A second feature of the biology of memory T cells of relevance to their
provenance is cellular longevity. Unlike their naive T cell progenitors, whose
lifespans are limited, at least in rodents (Tsukamoto et al., 2009; Sprent and
Surh, 2011), memory T cells have the capacity to persist for life (Homann et al.,
2001; Hammarlund et al., 2003; Lang and Nikolich-Zugich, 2011). Remarkably, in
experimental conditions of serial transplantation into successive young recipient
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mice, memory T cells have even been observed to exhibit lifespans that exceed
those of the original mice in which they were generated (Lau et al., 1994). What
is more, while naïve T cells protected from replicative stress nevertheless
unmistakably exhibit age-related decline in functionality (Decman et al, 2010),
similarly unstressed memory T cells retain functionality regardless of the passage
of time (Haynes et al., PNAS 2003; V. Decman and E.J. Wherry, unpublished
observations). That memory T cells can persist apparently indefinitely as well as
retain functionality – in stark contrast to naïve T cells and indeed most other
mammalian cell types – suggests that they must be endowed with protective
mechanisms that confer these extraordinary properties.
1.6.3 Pathogen-driven T cell expansion: a genotoxic maelstrom of mitosis
A third clue to memory T cell origins traces to the first and arguably most
important phase of adaptive immune responses. Before any given naïve T cell
encounters a pathogen for which it is specific, it exists in a state of metabolic and
proliferative quiescence that is actively maintained by various transcriptional
programs (Jones and Thompson, 2007; Feng et al., 2011). Following activation,
naïve T cells initiate a concerted phase of metabolic exertion, proliferation, and
differentiation in order to generate pathogen-specific effector T cells that are
sufficiently numerous to mediate organismal defense. Importantly, proliferation
of T cells during this period can be intense: in contrast to the staid cell cycles of
roughly 20 hours that characterize archetypal mammalian cell types (Posakony
et al., 1977; Baserga, 1985), pathogen-specific T cells can divide extremely
rapidly (Murali-Krishna et al., 1998; J. Yewdell, personal communication). In one
16

notable study, virus-specific naïve T cells labeled with a proliferation-tracking dye
were exposed to viral antigen in vivo, and subsequent division was monitored
every 24 hours for several days afterwards. Strikingly, cell division durations as
short as 3-4 hours were observed (Figure 1.1). Such extraordinarily swift
amplification is understandable in the context of the existential threat of an
interloping (and itself rapidly multiplying) microbe, though the molecular
mechanisms that underpin it are unknown. It is very likely however to have
important, probably deleterious consequences for genome integrity, as cell
division even in the most salutary of circumstances is inherently genotoxic. For
example, cells of every type are constitutively subjected to DNA damage,
including: nucleophlic attack by water leading to depurination and depyrimidation,
which occur at an estimated 10,000 bases/day/cell (Friedberg et al., 2005);
cytosine deamination (100 bases/day/cell); and oxidative damage from hydroxyl
radicals generated consequent to quotidian mitochondrial metabolism.
Importantly, repair of each of these genomic insults is facilitated by the fact they
occur on one strand of the double-helix, leaving the opposing strand as a
template for accurate repair (Ruzankina et al., 2008). During cell division
however, the double-stranded nature of DNA is suspended. This disruption
dramatically escalates the chance that any given error, minor and readily
reversible in most situations, might instead yield a mutation via misrepair or
neglect. Worse, un- or mis-processed damaged bases can interfere with or even
precipitate collapse of progressing replication forks, leading to potentially
catastrophic double-strand breaks (Ruzankina et al., 2008). In addition to these
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elevated risks from commonplace DNA damage, the incomplete fidelity of DNA
polymerases ensures that at least a handful of mutations will be generated for
every round of genome replication (Loeb and Monnat, 2008).
In short, even in the most leisurely of contexts, cell division is a risky
proposition. However, proliferating, pathogen-specific T cells cycle to an extreme
extent that is rarely observed in adult mammalian physiology. Given indications
that accelerated proliferation may be associated with threats to genome integrity
even beyond those inherent in standard, unhurried cell division (Cairns, 1975;
Wu et al., 2005; Martin et al., 2011; Schoppy et al., 2012), the genotoxic risk for
activated T cells responding to pathogens is likely to be enormous. Because the
cells in which immunological memory resides must transit this mitotic maelstrom
to survive and mediate potentially life-long defense against further pathogen
encounters, any explanation for the origins of memory T cells must take into
account this fundamental problem of information homeostasis.

1.6.4 Memory T cell origins and the paradox of genome integrity
homeostasis
While memory T cell origins remain a matter of debate, the several clues
discussed above help delineate the contours of possibility that must be
considered. First, T cells can divide extensively but not without limitation, and
proliferative history correlates with accumulation of (epi)genomic damage.
Second, at least in the absence of replicative stress, memory T cells can persist
for tremendously long periods, including without any apparent loss of
functionality. Given that almost every other known cell type exhibits an age18

related decline in quantity, quality, or both, these observations suggest that
memory T cells are endowed with protective mechanisms that enable these
characteristics of extraordinary longevity. Third, despite the fact that cell division
under any circumstances is inherently genotoxic, T cell proliferation is
tremendous in both scope and rate when responding to a pathogenic
perturbation. That memory T cells both survive this enormously stressful process
and also retain a capacity for further extensive and rapid division is an additional
indication suggesting the presence of mechanisms that minimize genotoxicity.
In sum, to effectively address the ever-present multiplicity of threats posed
by pathogens of all sorts, T cells need to be able to proliferate extensively, do so
extremely rapidly, and persist potentially for the duration of a lifespan. Each of
these individual stipulations constitutes a substantial threat of compromised
genome integrity and premature senescence. How these necessary yet
apparently mutually exclusive imperatives are reconciled amounts to a major
paradox in modern immunobiological inquiry: on one hand, extensive proliferation
and prolonged survival are required to generate and sustain immunity, while on
the other lies the existential pressure to avoid excessive division as well as the
inevitable genotoxic ravages of time so as not to prematurely exhaust finite
replicative potential. Simply put, how does the immune system manage
mortality? This essential question is the animating force for the research
presented in this dissertation, and it is suggested that the cradle of
immunological memory may be found in its answer.
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1.7 Stem cells as a solution to the genome integrity paradox
A possible explanation for this modern immunological conundrum concerns stem
cells. The evidentiary basis for this fundamental concept in developmental
biology began to emerge in the years before and shortly after the second world
war.
1.7.1 Four-dimensional anatomy: the history of tissue turnover
In 1937, the technique of autoradiography had just recently been pioneered by
Antoine Lacassagne in Paris, and the Institut du Radium at which he labored was
abuzz with excitement following the award of the 1935 Nobel prize in chemistry
to faculty members Frederic and Irene Joliot-Curie. This recognition was for the
discovery of methods to synthesize radioactive elements at will, which in turn
came about in the wake of the two Nobel prizes awarded in 1903 and 1911 to
Marie and Pierre Curie, Irene’s parents, for their discovery and isolation of
elemental radium and further, groundbreaking studies on the nature of
radioactivity. This string of scientific triumphs and the manifest potential of
radiolabeled molecules as tools in biological research attracted the substantial
funding necessary to construct a cyclotron at the Institut (Laurie, 2007). In this
well-resourced environment of intellectual ferment, post-doctoral trainee Charles
Leblond joined Lacassagne’s research group and mastered autoradiography.
Early observations demonstrated that metabolism of phosphorous and other
minerals in adult animal models was unexpectedly rapid. Importantly, these
findings began to undermine the then-prevailing paradigm of “cellular stability”, in
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which the principal physiological function of mitosis was held to be for growth
toward the end of achieving sexual maturity (Leblond, 1995); with minor
exceptions, the tissues of the human body, like the cogs and wheels of an
automobile, were thought to stable, permanent structures (Leblond, 1991).
However, addressing this matter definitively was precluded by technological
constraints, as the radiographical techniques of the time could visualize tissues
but not individual cells. World war interrupted this thread of inquiry, and
prompted Leblond to flee to Montreal. When research resumed at McGill
University, a fruitful collaboration with physicists coupled with exploitation of the
newly-available radioisotope tritium lead to a methodological breakthrough in the
form of a hundred-fold improvement in autoradiography resolution, and the
consequent ability to visualize single cells (Belanger and Leblond, 1946). For the
first time, the fourth dimension – that of time itself – was amenable for the study
of anatomy and physiology in vivo.
Using these newly refined autoradiography techniques, Leblond and
colleagues thereafter reported a conceptual breakthrough. By carefully
observing the kinetics of radionuclide labelling in the intestines of fully grown
rodents, they observed not rare but rather frequent mitoses in epithelial cells, and
calculated that the entire epithelium not only turned over regularly, but did so in a
mere matter of days (Leblond and Stevens, 1948; Leblond et al., 1948). This
notion was such a dramatic departure from the accepted model of post-growth
cellular stability that it was roundly dismissed, and even mocked by critics
(Bennett and Bergeron, 2007). Nevertheless, continued research in Leblond’s
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group and corroborating reports from others’ eventually established the modern
consensus that while many tissues in model organisms are indeed comprised of
mostly or even entirely quiescent cells, several – most prominently including
bone marrow, alimentary epithelia, epidermis, and the spermatogenic
compartment – rapidly turn over and continually renew themselves (Messier and
Leblond, 1960; Leblond, 1995). Recent developments in accelerator mass
spectrometry and biomedical adaptation of radiocarbon dating technology
commonly used in archeology have extended this paradigm to previously
inaccessible human tissues (Spalding et al., 2005).
The understanding that the lives of cells in multiple, critical tissues are
ephemeral rather than perpetual occasioned a profound rethinking of metazoan
physiology and raised numerous important questions. Perhaps foremost among
them: if multitudes of cells are being birthed and replaced on a regular and often
rapid basis, from where do new cells derive – what is the mechanism of selfrenewal (Dor and Melton, 2004)?

1.7.2 Discovery of somatic stem cells as the source of continuously
generated tissue effector cells
More than a century of independent, discursive threads of inquiry in
developmental biology and evolutionary theory culminated in a solution to this
problem. In a word: “stammzelle”, or stem cells, a concept that the eminent
German biologist Ernst Haeckel proposed in 1877 as he pondered how a single
cell – the fertilized egg – might undergo the wondrous transformations that
eventually give rise to the multitudes of cells and cell types that comprise the
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mature organism (Ramalho-Santos and Willenbring, 2007). Contemporaneous
investigations in embryology paralleled burgeoning research in hematology,
which sought to elucidate the relationships between and origins of the multiple
cell types that were coming to be appreciated in blood. As early as 1896, the
hematologist Artur Pappenheim hypothesized the existence of a single progenitor
cell that could give rise to both red and white blood cells (Pappenheim, 1896).
Later, as the various lineages of the hematopoietic system came into focus
following the promulgation of the staining techniques developed by Paul Ehrlich
in the 1870’s, he proposed a remarkably prescient genealogy of hematopoiesis
rooted in a “polyvalent stem cell” that resembles the accepted modern paradigm
(Ramalho-Santos and Willenbring, 2007).
Investigation into the nature of hematopoiesis continued in the following
decades, often on the basis of observation, supposition and deduction, as
opposed to direct demonstration. Following the atomic bombings of Hiroshima
and Nagasaki however, interest in and funding for the field intensified
dramatically when it was appreciated that blood was uniquely implicated in the
pathogenesis of radiation poisoning (Na Nakorn et al., 2002; Weissman, 2014).
A major goal in the field, inspired by the incipient Cold War and fears of
impending nuclear conflict, was to discover treatments for ameliorating or even
reversing this ghastly, greatly feared condition. Early experiments uncovered
that lead shielding of spleen or bones (but, for example, not kidneys) during
exposure to irradiation prevented mortality (Jacobson et al., 1951), and that pretreatment with certain substances, for example high dose cysteine, could
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attenuate subsequent radio-injury (Patt et al., 1949). However, cysteine
administration after irradiation was entirely ineffectual (Patt et al., 1949). The first
demonstrations of a post-hoc treatment arrived only when it was shown that
transplantation of spleens or bone marrow could rescue mortality in mice and
guinea pigs previously exposed to an otherwise-lethal dose of ionizing radiation
(Lorenz et al., 1951; Jacobson et al., 1951).
What was the mechanism of this hotly-anticipated cure for radiation
poisoning? Initial thinking in the field favored the hypothesis that humoral
substances present in the transplanted tissue somehow effected repair of
radiation lesions in the recipient hosts. This notion was discarded after a series
of elegant experiments exploiting novel xenochimaeric and chromosomal marker
strategies showed that the freshly-generated blood cells circulating in transplant
recipients after recovery were unambiguously derived from the donor and not the
recipient (Ford et al., 1956; Nowell et al., 1956), thus establishing the presence of
cells with tissue reconstituting activity in adult bone marrow (Weissman, 2014;
Eaves, 2015). Several years later, the dynamic Canadian duo of Ernest
McCulloch and James Till devised methodology to quantify this activity for the
first time, initially by way of a cumbersome limiting-dilution assay (McCulloch and
Till, 1960), and then substantially more tractably following the serendipitous
observation that otherwise-lethally irradiated mice whose hematopoietic systems
had been reconstituted manifested macroscopic nodules, or colonies on their
spleens approximately a week post-transplantation. Colony abundance
corresponded linearly to the number of bone marrow cells that had been
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transplanted, thus offering the ability to readily and rapidly (if retrospectively)
measure progenitor cell number (Till and McCulloch, 1961). Importantly, after
noting that the splenic colonies were comprised of multiple cell types including
erythrocytes, megakaryotcytes, granulocytes, macrophages, and lymphocytes,
the McCulloch and Till team then devised a clever method of uniquely
chromosomally marking single hematopoietic cells using low-dose irradiation.
Using this technique, they observed that the heterogeneous colonies were clonal:
that is, all cells in a given colony, irrespective of cell type, bore the same, unique
chromosomal marker, indicating descent from a common progenitor (Becker et
al., 1963; Wu et al., 1968). Shortly thereafter, demonstration that serial
transplantation of donor-derived colonies into secondary irradiated recipient mice
could themselves form new, multi-lineage colonies and also still rescue
otherwise-lethal radiation poisoning established the critical principal of
autopoiesis (Siminovitch et al., 1963) – the ability of a system to recreate itself,
often referred to somewhat less precisely as self-renewal.
Thus, the torrid, postwar quarter century of experimentation on irradiation
pathogenesis and blood formation birthed the theoretical and experimental
foundations upon which the modern concept of somatic stem cells is rooted.
These potent cells constitutively maintain, and upon injury can reconstitute their
tissue of origin by way of the capacities for extensive proliferation, (often but not
necessarily multi-lineage) differentiation, and self-renewal (Siminovitch et al.,
1963; Eaves, 2015). A preponderance of less direct, yet nevertheless compelling
experimentation synergized with these concepts in other tissues and
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developmental contexts, including epidermis (Storey et Leblond, 1951),
spermatogenesis (Clermont and 1953), and gastrointestinal epithelia (Cheng and
Leblond, 1974), thereby indicating that stemness is the biological force
underlying the continuous renewal of a panoply of both solid and liquid tissues,
especially those tending towards rapid turnover dynamics.
1.7.3 Genome integrity maintenance – the source of stemness?
Of course, at least within the tissues for which a clear role for stem cells had
been established, the great question then became: what is the nature of
stemness? What characteristics distinguish such cells from non-stem cells, and
in particular, what processes conduce to their remarkable, life-long generative
properties?
Clues to this puzzle began emerging piecemeal decades ago, but weren’t
consolidated into a coherent theoretical framework until a seminal publication
situated stem cells within the evolutionary dynamics of carcinogenesis (Cairns,
1975). From these considerations emerged a simple, critical question: given the
inherent genotoxicity of mitosis, how does rapid, ongoing cellular turnover in
multiple tissues not precipitate an untimely collapse of genome integrity and
consequent burden of cancer so overwhelming as to utterly squelch reproductive
fitness (much less survival into old age)? To reconcile this paradox, Cairns
posited that cellular and molecular mechanisms must exist that 1) minimize
genotoxicity in stem cells and 2) minimize the possible damage to organismal
homeostasis should accumulated mutations transform any given stem cell into a
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tumor (Cairns, 1975). Though some of Cairns’ specific predictions have not been
borne out, the overall framework he proposed to undergird the growing
evidentiary basis for emerging stem cell theory remains a touchstone in
contemporary developmental biology. Specifically, Cairns anticipated that key
stem cell characteristics would include: rarity, to restrict the overall size of the
long-lived compartment in which transforming mutations might accumulate;
relative proliferative quiescence, to indirectly minimize the accumulation of
mutations arising from cell division; and endowment with various molecular
mechanisms that actively promote the conservation of genome integrity (Cairns,
1975).
To varying extents, preceding and subsequently-published data have
substantiated each of these claims. A major finding that emerged from early
hematopoietic transplantation studies in the 1960’s was the fact that less than
1% of cells in the bone marrow are possessed of reconstitution potential (Fuchs,
2009), and stem cell populations that have been identified in other tissues are
almost uniformly tiny fractions of the total cellularity whose homeostasis they
support. With respect to cycling dynamics, during early histological examinations
of spermatogenesis in seminiferous epithelia, Leblond and colleagues deduced
the presence of spermatogonial stem cells and noted early on that they appeared
to be proliferatively quiescent relative to differentiating spermatocytes (Clermont
and Leblond, 1953). A decade later, early characterizations of hematopoietic
stem cells recorded resistance to radiation exposure and chemotherapeutic
drugs known to preferentially target dividing cells, thus suggesting that stem cells
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in liquid tissue appeared to also be marked by quiescence (Becker et al., 1965;
Bruce et al., 1966). More recent studies using pharmacological and genetic
label-retaining strategies have documented deep proliferative quiescence in
multiple somatic stem cell compartments (Cotsarelis et al., 1990; Wilson et al.,
2008; Tian et al., 2011; Bernitz et al., 2016), and established the general
principle that cycling frequency correlates inversely with (re)generative activity –
essentially that proliferative potential is a function of proliferative past (Fuchs,
2009). Cairns’ remaining prediction, that stem cells might be programmatically
specialized to actively forestall genomic disintegration, so far remains the least
supported. Briefly however, the activity of at least one important pathway of
genome integrity homeostasis appears to be substantially enriched in multiple
somatic stem cell compartments – that of telomerase and the maintenance of
telomere length (Vaziri et al., 1994; Flores et al., 2008). The possibility that
additional genome integrity conservation mechanisms might be at play in stem
cells is the subject of Chapter 3 in this work.
Thus, though minimally differentiated with respect to tissue effector
functions (e.g. oxygen ferrying or hemostatic capacity in blood, action potential
generation in brain, barrier function in the skin, or nutrient absorption activity in
the intestine) stem cells may in fact be highly specialized for the maintenance of
genome integrity through activation of multiple, independent pathways that
comprise both passive (e.g. proliferative quiescence) and active modalities (e.g.
DNA repair). Failure or exhaustion of these mechanisms accelerates
senescence and the loss of stemness (Allsopp et al., 2003; Rossi et al., 2007;
28

Bernitz et al., 2016). If self-renewal is the single most defining characteristic of
stem cells, a strong possibility is that genome integrity maintenance is the
essence of self-renewal (Rando, 2006).

1.8 Conclusions
In summary, a developmental hierarchy rooted in a rare yet potent stem cell
population that can repeatedly give rise to abundant effector cells appears to be
a fundamental, conserved strategy of renewal in multiple tissues and metazoan
species (Figure 1.2). This strategy is deployed to rapidly generate – or, upon
injury, to regenerate – cellularity in a manner that minimizes the inevitable loss of
(epi)genomic integrity consequent to cell division which would eventually lead to
either malignant transformation or loss of function and degeneration (i.e. aging).
Though the proliferative dynamics of tissues have been pondered since
the advent of cell theory almost a century and a half ago, and empirically
explored in increasing depth during the modern, postwar period, the full extent of
the role of stem cell hierarchies in somatic homeostasis remains unsettled. In
unprecedented detail, a spate of recent reports has elucidated surprising
turnover kinetics in tissues including brain, heart, and adipose tissue (Eriksson et
al., 1998; Spalding et al., 2008; Spalding et al., 2013; Bergmann et al., 2015),
rekindling in fresh contexts the long-standing question of the mechanism of lifelong cell renewal (Dor and Melton, 2004). In these newly-scrutinized tissues, in
others such as liver, pancreas, and skeleton, and even in well-studied tissues like
blood and intestinal epithelium, multiple, sometimes contrasting reports have
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emerged questioning, supporting, or substantially revising the role of stem cell
hierarchies (Tian et al., 2011; Smart et al., 2011; Ali et al., 2014; Sun et al., 2014;
Yanger et al., 2014; Chan et al., 2015, Kopp et al., 2016). Comprehensively
understanding this fundamental matter in each of the complement of tissues that
comprise the mammalian body plan remains of unsurpassed importance in
biomedical research given the tremendous implications for basic understanding
of physiological and pathological processes, as well as for the design of
interventional prophylactic and therapeutic applications to preserve or potentiate
human health.
Curiously, given the field of Immunology’s deep roots in basic principles of
developmental biology and the recognition of increasingly broad roles for
lymphocytes in organismal homeostasis, the intertwined matters of stemness and
genome integrity maintenance in the adaptive immune system have only recently
begun to receive serious attention. Broadly, this dissertation probes the
(re)generative nature of the adaptive immune system. Chapter 2 approaches this
from a cellular perspective, and presents the isolation and characterization of
rare, antigen-specific stem cells in the T lymphocyte compartment. These T
stem cells are shown to underwrite the extraordinarily rapid generation of
cytotoxic cells that effect defense against microbial infections. Surprisingly,
following the resolution of infection-injury, some differentiated, cytotoxic effector
T cells appear to de-differentiate and re-acquire stemness attributes, thus
challenging the cardinal rule of irreversible differentiation that has attended the
overall fields of hematology and immunology for decades. The broader context
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and implications of dedifferentiation for developmental biology and the aging
process are discussed. Chapter 3 probes the maintenance of genome integrity at
a molecular level, first with respect to two well-known pathways, those of
telomerase and double-strand break repair. The chapter concludes with a
presentation of preliminary evidence suggesting the existence of an entirely new
genome integrity maintenance mechanism involving endogenous transposons.
Chapter 4 asks how T stem cells manage intense mitogenic signaling pressure to
balance the opposing needs for active proliferation and differentiation to combat
an invading pathogen versus the imperative of quiescence to conserve future
proliferative potential. Observations are presented that T stem cells robustly
express PD-1 and multiple other signal-attenuating receptors, and do so in order
to prevent hyperactivation-induced depletion. The implications for immunological
memory formation and immunotherapy applications are discussed.
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Figure 1.1
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cell division (CFSE)

Figure 1.1: Precipitous proliferative dynamics of antigen-specific CD8+ T cells
responding to viral infection. LCMV-reactive TCR-transgenic P14 CD8+ T cells were
labeled with the proliferation-tracking dye CFSE and transplanted into naïve mice, which
were subsequently infected with LCMV-Armstrong. Proliferation – by way of CFSE
dilution – was monitored over the following 96 hours. After the adaptive immunological
reaction commences (~48 hours pi), CD8+ T lymphocyte division is rapid, with cell cycle
durations as short as ~4 hours. Adapted from Kurachi et al., 2014.
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Figure 1.2: Generic proliferative hierarchy rooted in a stem cell population. Stem
cell proliferative hierarchies in multiple vertebrate tissues sustain rapid, continuous
generation of abundant, terminally differentiated tissue effector cells. Asymmetric
division (depicted with a small, orange badge) and restrained progenitor proliferation
minimizes the loss of genomic integrity inherent to mitosis, thereby conserving
proliferative capacity to meet future physiological demand. Stem cells are depicted in
blue; transit amplifying cells in green; terminally-differentiated effector cells in red.
Number of divisions relative to the founding stem cell are indicated above. Adapted from
Clermont and Leblond, 1953; and Cairns, 1975.
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.:: CHAPTER 2 ::.
ISOLATION OF T STEM CELLS, AND DEDIFFERENTIATION OF
CYTOTOXIC LYMPHOCYTES INTO CD8+ CENTRAL MEMORY T
CELLS
Understanding how development of immunological memory is orchestrated has
extensive implications for vaccines, cancer immunotherapies, autoimmunity, and
possibly the aging process. The first chapter discussed this issue in the context
of the paramount requirement for the maintenance of genome integrity, and
suggested that the existence of a stem cell subpopulation might enable
pathogen-specific T lymphocytes to reconcile the apparently mutually-exclusive
goals of extensive and extremely rapid proliferation with avoidance of premature
exhaustion of finite proliferative potential.

2.1 Efflux activity (the side population phenotype) as an unbiased
technique for isolating novel somatic stem cell populations
Probing the hypothesis that somatic stem cells might underlie immunological
memory is conceptually straightforward yet technically challenging. A major,
long-standing issue in developmental biology is identifying stem cells for a tissue
of interest in the first place. Tissue stem cells were first imagined in the mid 19th
century, formally demonstrated to exist in the 1960’s, and only molecularly
defined and prospectively isolated in the late 1980’s following decades of
concerted inquiry in experimental hematology entailing laborious fractionation
and transplantation experiments (Spangrude et al., 1988). By evolutionary
design and biological definition (as discussed in Chapter 1) stem cells are
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exceedingly rare, and this fact has complicated and to this day continues to
complicate investigations into the nature of (re)generativity in any given tissue.
One practical method of circumventing much of this investigational
complexity arose in the late 1990’s based on observations originating in the
context of cancer pharmacology three decades previously. During the dawn of
anti-neoplastic chemotherapy, it was observed in treatment of both patients and
transformed cell lines in vitro that resistance arising against one drug often
engendered cross-resistance to a range of other drugs with disparate chemical
structures and biological modes of action (Kessel et al., 1968). This phenomenon
became known as multidrug resistance and is one of the most frequent forms of
chemotherapy resistance (Muller et al., 1994). Mechanistic dissection of this
process led first to the biochemical (Juliano and Ling, 1976) and ultimately the
genetic isolation (Gros et al., 1986; Cole et al., 1992; Doyle et al., 1998) of the
molecular factors involved, which turned out to be a subset of the ABC
superfamily of transporters with promiscuous substrate specificities. These ATPdependent enzymes are embedded in the plasma membrane and extrude a
broad range of structurally diverse, xenobiotic substrates (including
chemotherapeutic agents) from the cell against a concentration gradient
(Schinkel and Jonker, 2003). This activity decreases intracellular drug
concentration and thus confers resistance.
Separately, ongoing characterization of hematopoiesis coupled with
advances in flow cytometry technology generated the intriguing insight that
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hematopoietic stem cells (HSC) efficiently extrude certain fluorescent dyes such
as Rhodamine-123 and Hoechst-33342, and that this property could be used to
crudely isolate rare HSC from the complex and far more abundant mixture of
non-stem-cell bone marrow cells that readily take-up and retain dyes (Pallavicini
et al., 1985; Spangrude and Johnson, 1990). Using newly-generated monoclonal
antibodies, a subsequent study elucidated the mechanistic basis for this:
although broad, expression of MDR-related ABC proteins was observed to be
particularly high on HSC, and furthermore correlated with fluorescent dye efflux
activity (Chaudhary and Roninson, 1991). A methodological refinement several
years later led to the observation of a so-called “side population” phenotype in
which dye-stained bone marrow cells evaluated flow cytometrically exhibited
strong, dual-emission peak fluorescence throughout, except for a visually distinct,
quantitatively minor fraction of cells at the lower end of the spectrum of staining
intensity. This fraction was isolated and shown in transplantation experiments to
contain the vast majority of HSC activity (Goodell et al., 1996). Further studies
genetically potentiating or abrogating expression of the MDR-related ABC genes
ABCB1 and ABCG2 directly confirmed that these were principally responsible for
the side population phenotype, and revealed that hematopoietic cells genetically
deficient in efflux capacity were hypersensitive to chemotherapeutic drugs and
other xenobiotics (Bunting et al., 2000; Zhou et al., 2001; Zhou et al., 2002).
Perhaps most importantly from the broader perspective of developmental
biology, the efflux / side population staining technique perfected by Goodell et al.
enabled HSC to be isolated with remarkable ease and purity on the basis of a

36

defined physiological capacity, i.e. without any other a priori knowledge of HSC
biology (e.g. unique proteomic or transcriptomic signatures). Together with
Chaudhary and Roninson’s earlier observation, this indicated the possibility that
heightened efflux capacity might be an important aspect of stem cell biology
generally, and offered the unprecedented opportunity to explore this notion in a
methodologically tractable manner. Indeed, wide deployment of the side
population technique subsequently uncovered confirmed or candidate stem cell
populations in multiple tissues, including muscle, intestinal epithelium,
endometrium, breast, testis, brain, solid tumors, and liquid tumors (Lassalle et al.,
2004; Challen and Little, 2006; Golebiewska et al., 2011; Maruyama et al., 2013;
von Furstenberg et al., 2014) and even across multiple species (Goodell et al.,
1997). Thus, the “side population” technique of isolating candidate stem cell
populations on the basis of a physiological profile of uniquely efficient dye efflux
capacity can be a broadly effective strategy for discerning the presence of and
initially isolating a putative stem cell population with an unknown proteomic
signature (i.e. marker profile) in any given tissue. In short, the side population
technique can sidestep much (though not necessarily all) of the laborious,
iterative fractionation associated with historical searches for stem cells.

2.2 Efflux activity in antiviral CD8+ T cells identifies CD62L as a
candidate marker of T stemness
Given its demonstrable utility in identifying or clarifying progenitor cells in a
multitude of other contexts, the side population technique seemed an opportune
approach to begin to address the theoretical possibility that a rare population of
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stem cells might exist within the sizeable pool of T lymphocytes that respond to
invading pathogens. Since it is likely that the greatest threat to T cell genome
integrity arises consequent to the hyper-proliferation, intense metabolism, and
elaborate epigenetic transformations that attend the expansion phase of the
adaptive immune response to pathogen invasion (as discussed in Chapter 1),
and since stem cells are perhaps most likely to be physiologically required or at
least experimentally evident in this context, analysis was focused primarily on
this initial, priming period. As such, mice (C57Bl/6 strain) were infected
intraperitoneally with the acutely-resolving, Armstrong strain of LCMV. A single
cell suspension of splenocytes was prepared from spleens harvested during the
expansion phase of the infection (d6 pi), incubated with Hoechst 33342 dye, and
counter-stained with both fluorochrome-conjugated antibodies against a panel of
surface proteins and a peptide-MHC tetramer to distinguish virus-specific T cells.
When H33342 fluorescence was visualized simultaneously at 450 nm and 675
nm, a quantitatively minor side population was plainly evident in CD8+ T cells
(Figure 2.1, left). This was intriguing, and suggested the possibility that a
subpopulation of CD8+ T cells with stem cell characteristics might actually exist.
To facilitate investigation of the cells in this side population, it was
desirable to identify cell surface antigens that could distinguish them. Prior
literature has established that side populations and non-side populations are
antigenically distinct in multiple tissues (Challen and Little, 2005). Therefore,
expression of a panel of markers of known relevance to memory CD8+ T cell
differentiation was screened in the side population versus the non-side
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population of CD8+ T cells during the expansion phase of the response to viral
infection. From this it emerged that the protein CD62L was expressed to a
greater extent in the side population, rather substantially in the total population of
CD8+ T cells (Figure 2.1, right) and less dramatically in the LCMV GP33-41specific subpopulation thereof (discussed later in the chapter).

2.3 Scrutiny of cellular heterogeneity during the antiviral expansion
phase and re-evaluation of effector/memory T cell differentiation
models prompted by unexpected expression of CD62L
The selectin CD62L is a cell adhesion molecule that interacts with specialized
endothelial cells in lymphoid tissues and thereby plays an important role in the
homing of lymphocytes (Gallatin et al., 1983). That CD62L was expressed
preferentially in the side population of antigen-specific CD8+ T cells suggested
the possibility that this readily-measurable antigen might possibly be a marker for
a hypothesized T stem cell subpopulation. However, that CD62L was expressed
at all on antigen-specific T cells during the antigen-driven expansion phase of
robust LCMV infection was unexpected, given the predominant consensus that
all CD8+ T cells during the expansion phase are firmly engaged with and
committed to the effector fate; that such effector cells are marked by the absence
of CD62L protein expression, and that any expression of CD62L during antiviral
T cell expansion is negligible or at most irrelevant; and that instead CD62L
expression marks preceding naïve T cells and succeeding T cells that emerge
from effector T cell progenitors and subsequently commit to the memory fate
weeks after antigen clearance and resolution of an acute infection (Kaech et al.,
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2002; Wherry et al., 2003; Masopust, Murali-Krishna, et al., 2007; Pauken and
Wherry, 2015). This surprising observation prompted closer scrutiny of
heterogeneity in CD8+ T cells in the expansion phase of the immunological
response to viral infection, and a re-assessment of the principal models for
memory T cell differentiation.

2.3.1 Contrasting developmental models for memory T cell formation
Despite the numerous mechanistic insights into the origins of T cell memory that
have been gained in recent years, considerable debate remains concerning how
long-lived memory CD8+ T cells form (Ahmed et al., 2009; Kaech and Cui, 2012;
Restifo and Gattinoni, 2013). Two distinct models have been proposed to
explain this process. First, the post-effector model proposes that long-lived, selfrenewing memory CD8+ T cells are the progeny of cytotoxic effector CD8+ T cells
that emerge during the expansion phase. This model is supported by lineage
tracing experiments that defined the developmental relationships of effector and
memory T cells (Jacob and Baltimore, 1999; Opferman et al., 1999; Kaech et al.,
2003; Wherry et al., 2003; Joshi et al., 2007; Sarkar et al., 2007; Harrington et
al., 2008; Bannard et al., 2009). Functional studies also failed to observe CD8+ T
cells with key memory properties during the expansion phase, supporting the
notion that memory CD8+ T cells differentiate from surviving effector CD8+ T cells
following the clearance of antigen (Kaech et al., 2002). An alternative model
proposes that memory T cells arise prior to effector T cell formation, and that
effector T cells are generated from the progressive differentiation of memory T
cells (Sallusto and Lanzavecchia, 2011; Restifo and Gattinoni, 2013; Fuertes
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Marraco et al., 2015). Recent observations of phenotypic heterogeneity arising
as early as the first division of activated naive cells (Chang et al., 2007; Metz et
al., 2016) are consistent with a model in which the emergence of memory T cells
does not require transit through an effector stage. Thus, the literature is tangled
in a classic chicken-and-egg problem of ontogeny, with dueling models proposing
either that cytotoxic effector differentiation exclusively precedes memory
differentiation, or alternatively, the converse. Discerning which (if either) of these
models most accurately reflects biological reality has been a long-standing goal
in immunology and has tremendous implications for basic principles of
developmental biology as well as numerous applications with relevance to
human health. Here, this challenge is addressed directly. Data are presented
that elucidate classical concepts of stem cell biology in danger-driven peripheral
cytotoxic T lymphopoiesis, and also identify an unexpected and
hematopoietically-unprecedented pattern of effector T cell de-differentiation in the
post-antigen phase that plays an important yet non-essential role in memory T
cell formation. Together, these findings support both pre- and post-effector
models of CD8+ T cell memory formation and conduce to a unified framework for
memory T cell ontogeny.

2.4 Characterization of a CD8+ T cell subset present during the
expansion phase that expresses CD62L
To further investigate the surprising result of the side population assay – in which
a sub-population of CD8+ T cells expressing CD62L despite the presence of
antigen was revealed – the heterogeneity of antigen-specific CD8+ T cells was
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scrutinized during the antigen-driven clonal expansion phase of acutely resolving
viral infection. Previous work has identified IL-7Rα and KLRG1 as markers that
define so-called “memory precursor” and terminally differentiated effector CD8+ T
cell subsets, respectively (Kaech et al., 2003; Huster et al., 2004; Joshi et al.,
2007). While the great majority of cells within the splenic KLRG1lo IL-7Rαhi
subset lacked robust expression of CD62L protein, clearly evident was a distinct
subpopulation of LCMV GP33-41-specific, TCR-transgenic P14 CD8+ T cells with
pronounced CD62L expression at d8 pi with LCMV-Armstrong (Figure 2.2). The
presence of this KLRG1lo IL-7Rαhi CD62Lhi subset in the expansion phase was
not unique to P14 TCR-transgenic CD8+ T cells or LCMV and was observed in
CD8+ T cell responses to bacterial and other viral infections (Figure 2.3), as well
as in endogenous, non-TCR-transgenic responses to LCMV (Figure 2.4).
CD62L-expressing cells were also evident in other sub-populations defined by
KLRG1 and IL-7Rα, but were most frequent and most consistently present
across different infection types in the KLRG1lo IL-7Rαhi population (Figures 2.2
and 2.3).
CD8+ T cells expressing CD62L despite the presence of antigen have
been observed previously (Wherry et al., 2003; Wherry et al., 2004; Huster et al.,
2004; Marzo et al., 2005; Sarkar et al., 2007, Lin et al., 2016), but detailed
examination of the properties of such cells is lacking, especially in contexts not
complicated by supraphysiological manipulations (e.g. the use of TCR-transgenic
naïve precursor T cells spiked in at extremely high frequencies) that greatly ease
experimentation yet substantially compromise interpretability. Thus, to dissect
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the properties of CD62L-expressing cells to the greatest extent possible, the
expression of additional phenotypes and markers of effector and memory CD8+ T
cell differentiation was analyzed in the CD62Lhi KLRG1lo IL-7Rαhi subset
(depicted in blue; hereafter called the CD62Lhi subset for simplicity). While these
cells retained expression of CD95, Bcl-2, and the transcription factor TCF-1 at
levels similar to those of naïve CD8+ T cells, this subset also robustly
upregulated expression of numerous markers of activation and differentiation,
including CD44, CD38, CXCR3, CD122, IL-18R, Sca, CD27, and CD28 (Figures
2.5A and 2.5D). The transcription factor Eomes is required for optimal central
memory CD8+ T cell formation following acutely-resolving infection (Banerjee et
al., 2010; Zhou et al., 2010; Paley et al., 2013). Eomes was highly and
preferentially upregulated in the CD62Lhi subset at d8 pi compared to naïve CD8+
T cells (depicted in grey) or compared to the CD62Llo KLRG1lo IL-7Rαhi (depicted
in green; hereafter called the IL-7Rαhi subset) or the CD62Llo KLRG1hi IL-7Rαlo
(depicted in red; hereafter called the KLRG1hi subset) effector subsets (Figure
2.5A). In contrast, T-bet and Blimp-1, transcription factors that coordinately
specify effector CD8+ T cell differentiation (Intlekofer et al., 2005; Rutishauser et
al., 2009; Xin et al., 2016), were modestly upregulated in the CD62Lhi subset
relative to naïve precursors, but to a markedly lesser extent compared to the IL7Rαhi or KLRG1hi effector subsets (Figure 2.5A). As expected given initial
results indicating greater expression of CD62L in the CD8+ side population, efflux
activity was markedly enriched in the CD62Lhi subset relative to the IL-7Rαhi and
KLRG1hi subsets (Figure 2.6).
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The phenotypic characteristics of this expansion phase CD62Lhi subset
shared some features with previously described putative memory stem cells
(TSCM) in terms of CD95, CXCR3, and Sca expression (Restifo and Gattinoni,
2013). However, these previous studies also suggested that TSCM are more akin
to naïve CD8+ T cells, including, in some cases, low expression of CD44 (Zhang
et al., 2005; Gattinoni et al., 2009), which differs from the CD62Lhi subset
identified here that are clearly distinct from naïve CD8+ T cells and are CD44hi
(Figures 2.5A and 2.5D). Moreover, relative to naïve CD8+ T cells, the effectorassociated molecules Granzyme A and Granzyme B were modestly upregulated
in the CD62Lhi subset (Figures 2.5C and 2.5D), though expression of these
molecules was higher in the IL-7Rαhi or KLRG1hi subsets. This CD62Lhi subset
also readily expressed the cytokines IFNγ and TNF upon antigenic restimulation
ex vivo (Figure 2.5B), but was the only expansion-phase population that
efficiently produced IL-2 (Figure 2.5B). Thus, during the expansion phase of
LCMV infection the CD62Lhi subset exhibits phenotypic and functional features of
CD8+ T cell memory as well as limited effector differentiation.
One possibility was that these CD62Lhi cells simply were not fully activated
following antigen encounter. However, vital-dye-mediated proliferative history
tracking using physiological numbers of LCMV GP33-specific TCR-transgenic
P14 CD8+ T cells demonstrated that the vast majority of cells in the CD62Lhi
subset had undergone at least 8 divisions by the peak of expansion (Figure 2.7).
These findings unambiguously preclude the possible interpretation that the
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CD62Lhi population might be merely an artifact of incomplete recruitment (i.e.,
aberrant or aborted activation) of naïve CD8+ T cells into the immune response,
as has been observed in some experimental scenarios (Kaech and Ahmed,
2001).
Interestingly, the proliferative history data for all three antigen-specific
populations indicated that the CD62Lhi subset divided fewer times than the IL7Rαhi and KLRG1hi subsets. This pattern was modestly evident in contexts of
physiological numbers of precursor naïve P14 T cells, and substantially more so
when supraphysiological numbers were used (Figures 2.8A and 2.8B). Thus, it
appeared that CD62Lhi cells were distinguished not only functionally and
phenotypically, but also by unique proliferative dynamics. To probe this matter in
greater depth, multiple independent methods were used to monitor cell division in
the CD62Lhi, IL-7Rαhi, and KLRG1hi subsets towards the end of the expansion
phase. Short-term (24 hr) BrdU pulsing from d7-8 pi, Ki-67 expression at d8 pi,
and TCR-transgenic P14 CD8+ T cells on a Fucci-transgenic cell cycle reporter
background (Sakaue-Sawano et al., 2008) all indicated less cell cycling in the
CD62Lhi subset compared to the other two subsets between days 7-8 pi (Figure
2.8C). This hierarchy of proliferation was reflected in the absolute abundance of
cells in each subset that had accumulated in the spleen at the peak of the
expansion phase (Figure 2.8D). As such, the CD62Lhi subset of CD8+ T cells
identified in the expansion phase exhibits a distinctive pattern of differentiation
including robust expression of key factors associated with T cell memory and
minimal expression of effector-associated molecules. Moreover, these cells had
45

proliferated extensively, indicating they were not simply weakly activated, and yet
nevertheless exhibited a degree of proliferative quiescence relative to more the
more rapidly-cycling IL-7Rαhi, and KLRG1hi subsets. Together, these
observations suggested that CD62Lhi cells may have unique characteristics
among the pool of CD8+ T cells responding to infection in vivo, and raise the
question of what their developmental role might be.

2.5 Self-renewal of the CD62Lhi subset and ontogenetic relationship
to effector and memory lineages
The functional, phenotypic, and proliferative characteristics of the CD62Lhi subset
in the expansion phase suggested possible connections both to emerging
concepts (that is, within the field of immunology) of stem cell biology as well as
well-established T cell memory. However, the developmental relationship
between this subset and the two known CD62Llo effector CD8+ T cell subsets as
well as long-term memory CD8+ T cells was not clear. To address these
questions, it was important to delineate the lineage relationships between the
CD62Lhi, IL-7Rαhi, and KLRG1hi subsets in vivo, and define the contribution of the
CD62Lhi subset to long-term memory. Thus, the three subsets were flow
cytometrically isolated at d6 pi and transplanted into separate, congenicallydisparate recipients at d4 pi (Figure 2.10A). All donor populations were labeled
with a proliferation tracking dye. The numerical recovery, proliferation, and
developmental potential of each subset was then assessed at the peak of the
expansion phase of the infected recipient animals. At d8 pi the CD62Lhi subset
had given rise to the most abundant population of virus-specific progeny, the vast
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majority of which had extensively proliferated as indicated by full proliferation dye
dilution (Figure 2.10B, 4C). The IL-7Rαhi subset also gave rise to many dyediluted cells, but the numerical recovery was lower than for the CD62Lhi subset.
In contrast, the KLRG1hi subset gave rise to few recovered cells and many of
these cells had not extensively divided. These observations are consistent with
the terminal nature of the KLRG1hi subset of effector CD8+ T cells. These data
also identify the CD62Lhi subset as a population with superior ability to generate
progeny during antigen-driven clonal expansion.
The three different donor subsets also differed in their capacity to give rise
to progeny cells in each of the other CD8+ T cell subsets. The terminallydifferentiated KLRG1hi subset gave rise almost exclusively to progeny with an
identical phenotype (Figures 2.10D and 2.10E). IL-7Rαhi effector CD8+ T cells
gave rise to both IL-7Rαhi and KLRG1hi progeny, but did not appreciably produce
CD62Lhi cells in this expansion-phase assay (Figs. 4D and 4E). By contrast,
CD62Lhi cells generated all three subsets including additional CD62Lhi cells
(Figures 2.10D and 2.10E). This latter observation, together with the CTV
dilution data demonstrating that nearly all cells of the CD62Lhi donor subset
divided (Figure 2.10C), is consistent with self-renewal of the CD62Lhi subset in
this setting of antigen-driven proliferation. Thus, a positive association was
revealed between developmental potential and proliferative output: the CD62Lhi
KLRG1lo IL-7Rαhi subset is endowed with self-renewal capacity and the broadest
developmental potential. Consistent with established principles of stem cell
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biology, this subset also appeared to possess the greatest proliferative reserve
and capacity to generate abundant new progeny.
It was next of interest to probe the relationship of this CD62Lhi progenitor
subset to well-defined CD8+ T cell memory present following the clearance of
antigen. A cardinal attribute of CD8+ T cell memory is the capacity to persist in
the absence of antigen and mount a proliferative recall response to antigenic reencounter (Kaech and Wherry, 2007). Thus, each of the three CD8+ T cell
subsets were sort-purified from the peak of the expansion phase of viral infection
and transplanted in equal numbers to separate, naive recipient mice. A month
later, these recipient mice were challenged with the persisting, clone 13 strain of
LCMV and the expansion and phenotype of cells derived from each of the donor
subsets was examined. One week following rechallenge, robust recall (Figure
2.12A) and the presence of CD62Lhi cells (Figure 2.12B) were evident in the
progeny of the CD62Lhi progenitor subset, indicating the capacity to persist,
mount a vigorous proliferative response upon antigen re-encounter, and selfrenew. The IL-7Rαhi subset also manifested recall capacity, though to a lesser
extent than the CD62Lhi subset, raising the possibility that this IL-7Rαhi subset
had acquired at least some attributes of the memory fate despite substantial
effector differentiation during the expansion phase (Figure 2.5). The KLRG1hi
subset, as expected (Joshi et al., 2007; Sarkar et al., 2008), gave rise to few cells
capable of mediating effective recall responses. In a related experiment, the
three CD8+ T cell subsets were sort-purified from the peak of the expansion
phase of viral infection, transplanted into separate naïve recipient mice, and
48

challenged with LCMV clone 13 immediately (as opposed to one month later)
(Figure 2.13A). Approximately three weeks post challenge a comparable
hierarchy of donor-derived cell abundance was evident, with the progeny of the
CD62Lhi subset clearly advantaged over those of the two CD62Llo effector
subsets (Figure 2.13A). To ensure that these observations weren’t skewed by
any differences in environmental variables including viral load, this experiment
was repeated but modified to co-transplant congenically disparate CD62Lhi and
IL-7Rαhi subsets into the same recipient mice, followed by immediate challenge
with LCMV clone 13. Nine days post challenge the progeny of the CD62Lhi
subset substantially outnumbered those of the IL-7Rαhi subset (Figure 2.13B).
Thus, the CD62Lhi subset appears to be endowed with robust recall capacity that
is superior to that of cells lacking CD62L expression; it also appears to be
markedly advantaged with respect to proliferative capacity and/or survival ability
in the context of immediate and enduring replicative stress.
These observations prompted further probing of the phenotypic and
functional attributes of cells derived from antigen-specific, expansion-phase
subsets adoptively transferred into antigen-free recipient mice. Thus, the
CD62Lhi or IL-7Rαhi subsets isolated at d8 pi and transplanted into naive recipient
mice to examine antigen-independent maintenance differentiation status with
respect to cardinal attributes of central memory. The KLRG1hi effector subset
persisted poorly under these conditions (data not shown), consistent with data
above (Figures 2.10, 2.12, 2.13) and published observations (Joshi et al., 2007;
Sarkar et al., 2008). Following transplantation of the CD62Lhi subset, the donor
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cells recovered were mostly CD62Lhi six months (Figure 2.11A-B) or two weeks
later (Figure 2.11C-D). Moreover, cells in the CD62Lhi subset were able to
undergo homeostatic proliferation between days 8-21 pi more efficiently than
cells that lacked CD62L expression or cotransferred, control naïve OT-1 cells
(Figure 2.11E). These characteristics align with the well-described properties of
central memory (Sallusto et al., 1999; Wherry et al., 2003), and suggest that the
pool of CD62Lhi memory CD8+ T cells in the post-antigen phase draws
substantially from the CD62Lhi subset in the expansion phase. Indeed,
phenotypic and functional examination of the CD62Lhi subset during the
expansion and the post-antigen phases revealed both core similarities (e.g.
heightened anticipatory DNA damage surveillance) as well as differences (e.g.
extent of CD43 and CD62L expression) suggesting that fundamental memory
properties are engendered during the antigen-driven expansion phase, and
perhaps further evolve following antigen clearance (Figure 2.14).
Because the entire IL-7Rαhi subset (i.e. independent of CD62L expression)
has previously been shown to be the source of long-lived memory CD8+ T cells
(Kaech et al., 2003), it was important to determine whether this central memory
developmental potential could be fully explained by the expansion phase CD62Lhi
subset. Thus, the IL-7Rαhi subset (i.e. IL-7Rαhi cells depleted of CD62Lhi cells;
>99% of sorted cells were CD62Llo) isolated at d8 pi was transplanted to antigenfree mice. Six months (Figure 2.11A-B) and two weeks (Figure 2.11C-D) posttransfer a substantial fraction of cells derived from IL-7Rαhi CD62Llo donor cells
now expressed CD62L as well as CXCR3, an additional phenotypic feature of
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central memory. IL-7Rαhi CD62Llo-derived cells also displayed evidence of
homeostatic proliferation (Figure 2.11E) consistent with long-term, self-renewing
memory CD8+ T cells arising from CD62Llo IL-7Rαhi effector CD8+ T cells. Thus,
while the expansion phase CD62Lhi subset examined here is endowed with
multiple stemness characteristics and contributes to the pool of long-term
memory CD8+ T cells, the IL-7Rαhi effector subset, partially differentiated
consequent to intense antigenic and inflammatory signaling, surprisingly also
appears possessed of memory potential, albeit at a markedly lower efficiency
than the CD62Lhi subset. This observation of unanticipated developmental
plasticity is consistent with the notion of dedifferentiation, a phenomenon that has
been recently appreciated in other mammalian tissues but that is unprecedented
in hematopoietic lineages (Figure 2.15).

2.6 Discussion
There has been considerable debate concerning the ontogeny of long-lived
memory T cells. Here, a subpopulation of antigen-specific CD8+ T cells is
identified during antigen-driven expansion that in fact robustly expresses CD62L.
This CD62Lhi population of CD8+ T cells manifests a unique constellation of
properties – including multiple stem cell-like characteristics – that distinguishes it
from other CD8+ T cell subpopulations identifiable in the presence of antigen.
Examination of this rare CD62Lhi population has provided a fresh perspective on
the formation of long-lived memory T cells.
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2.6.1 CD62Lhi cells constitute a distinct subpopulation of expansion-phase
CD8+ T cells
The data presented suggest that the CD62Lhi subset makes a robust contribution
to immunological memory. These cells have an immunophenotype (e.g. KLRG1lo
IL-7Rαhi CD122hi CD27hi CD44hi) suggesting that they are more closely related to
previously described memory precursor cells (Kaech et al., 2003; Huster et al.,
2004) than to terminally differentiated, cytotoxic effector cells. However, in both
form and function, the rare CD62Lhi subset is clearly distinct from the more
abundant CD62Llo subset of KLRG1lo IL-7Rαhi cells classically referred to as
“memory precursors.” The CD62Lhi subset expresses more CXCR3 and less
CX3CR1, and, unique among antigen-specific cells in the expansion phase,
highly expresses a multitude of molecules implicated in progenitor biology
including Sca, a marker of hematopoietic stem cells in the bone marrow and a
determinant of their developmental potential (Spangrude et al., 1988; Ito et al.,
2003); CD47, a molecule on hematopoietic stem cells that interacts with SIRPα
on macrophages to provide protection from errant phagocytosis in inflammatory
milieux (Jaiswal et al., 2009); and TCF-1, a critical executor of the of the ancient
Wnt signaling pathway that animates self-renewal activity in numerous
embryonic, somatic, and cancer stem cell populations (Reya et al., 2003; Reya
and Clevers, 2005). As detailed in chapters 3 and 4, additional progenitorassociated molecules expressed by the CD62Lhi subset include telomerase
(Morrison et al., 1996), and CXCR5 (Wu et al., 2015; He et al., 2016; Im et al.,
2016; Leong et al., 2016). Notably, the activities of many of these progenitorassociated factors have also been implicated in memory fate commitment in both
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CD8+ and CD4+ T cells (Kaech et al., 2002; Gattinoni et al., 2009; Van et al.,
2012; Lin et al., 2016).
In addition to progenitor-associated molecules, expansion-phase CD62Lhi
CD8+ T cells exhibited the lowest expression of the effector-fate-promoting
transcription factors T-bet and Blimp-1, and were unique in their high expression
of the memory-fate-promoting transcription factor Eomes and ability to synthesize
the memory-associated cytokine IL-2. Despite their proliferative quiescence
relative to the CD62Llo effector subsets, these cells nevertheless had divided at
least 7-10 times by the peak of the expansion phase and had acquired the ability
synthesize the effector-associated cytokines IFNγ and TNFα. Moreover, these
cells retained robust proliferative capacity and could give rise to all effector
subsets while simultaneously regenerating themselves. Together, these data
describe a set of properties that identify this CD62Lhi subset of antigen-specific
CD8+ T cells arising in the expansion phase as a distinct cell type with substantial
relevance both for generating abundant cytotoxic effector cells in the presence of
antigen signaling, and for contributing to long-term T cell memory following
infection resolution and antigen clearance.

2.6.2 Implications of the Side Population / efflux phenotype
An intriguing aspect of the differentiation state of the CD62Lhi population was its
preferential efflux activity (i.e. relative to the two CD62Llo effector populations), as
identified in the side population assay. In these studies, CD62L as a marker of
progenitor T cell populations first came to light in the context of a quest using this
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assay for long-hypothesized T stem cells. In retrospect, this association between
CD62L expression and efflux activity is not surprising, given that the transcription
factor FoxO1 is a positive upstream regulator of the ABC-family pump Mdr1
(Kang et al., 2010), and preliminary indications that FoxO1 is highly expressed in
the CD62Lhi population (data not shown). Another ABC-family pump strongly
implicated in multi-drug resistance and efflux activity is Bcrp. This factor is known
to be upregulated on hematopoietic progenitor cells by hypoxia (Krishnamurthy et
al., 2004). Of note, lymphoid tissue is often hypoxic, with oxygen tension ranging
from 1-5% (Caldwell et al., 2001), and the CD62Lhi population is preferentially
localized thereto (discussed in Chapter 4). Thus, expression of FoxO1 and
localization to a hypoxic microenvironment are likely factors involved in regulating
the efflux activity of the CD62Lhi population.
Matters of regulation notwithstanding, the precise role of efflux in antigenspecific CD8+ T cells remains unclear. Since mice (and particularly their stem
cells) genetically deficient in ABC-family efflux pumps are highly susceptible to
the cytotoxic effects of ABC-family efflux substrates such as chemotherapeutic
drugs or endogenous porphyrins generated as a byproduct of quotidian
metabolism (Jonker et al., 2002; Zhou et al., 2002; Krishnamurthy et al., 2004), a
likely possibility is that efflux activity minimizes exposure to cytotoxic substances
and thus potentiates long-term survival of progenitor populations. An additional,
non-exclusive possibility is that ABC-family pump substrates include endocrine or
paracrine pro-differentiation factors. Thus, efflux capacity in cell populations with
stemness characteristics may assist in the maintenance of the undifferentiated
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(with respect to effector function) state — a fundamental aspect of self-renewal.
There is some precedent for this in other systems (Challen and Little, 2005; Lin
and Goodell, 2006). Future studies should address this possibility directly in the
CD8+ T cell progenitor compartment, possibly beginning with a biochemical
survey of substrates associated with ABC-family efflux pumps expressed therein.
Additionally, mice genetically deficient for ABC-family factors (e.g. Bcrp and
Mdr1) and upstream regulators thereof (e.g. FoxO1) are available, and can be
used to directly address some of the many questions raised by the efflux activity
of CD8+ T cells during pathogen infection: is efflux activity at all diminished
consequent to FoxO1 deficiency or relative oxygen abundance? Is the
differentiation or maintenance of the CD62Lhi progenitor population impaired in
the absence of ABC family members, both in unmanipulated conditions and
those of deliberate exposure to cytotoxic substances (e.g. chemotherapy
treatment)?
2.6.3 Transcriptional circuitry and fate determination
The transcription factor expression pattern of the expansion phase CD62Lhi
subset – TCF-1hi Eomeshi and T-betlo Blimp-1lo – would be expected to promote
the memory fate and suggests a distinct inductive event for these cells. One
possibility is that TCF-1 expression is sustained or induced in the CD62Lhi subset
via preferential Wnt signaling, as has been suggested using models of in vitro
priming in the presence of Wnt3a (Gattinoni et al., 2009), or via asymmetric
partitioning of Wnt signaling cascade factors (Lin et al., 2016). Additionally, or
alternatively, the expression pattern of key chemokine receptors (e.g. CX3CR1lo
55

CXCR3hi CXCR4hi CXCR5hi) and lymphoid localization bias in vivo suggest these
cells may have preferential access to signals that induce early commitment to the
memory fate (discussed in Chapter 4). Whether this reflects instructive signals
from antigen presenting cells as might occur during asymmetric division or
whether preferential access to cytokine or growth and differentiation factors
influences these decisions is unclear. Regardless, it will be of considerable
interest in the future to determine how these cells acquire their unique
differentiation state.

2.6.4 Reconciliation via dedifferentiation: toward a unified model of T cell
memory formation
“In science, ideology tends to corrupt; absolute ideology [corrupts] absolutely”
- Robert Nisbet
The data presented herein concerning the existence of a proliferative hierarchy
and the lineage relationships between CD62Lhi progenitor cells and CD62Llo
effector cells bear obvious implications for models about the formation of
immunological memory. One model of memory CD8+ T cell formation posits that
memory fate commitment occurs early after initial activation such that memory
and effector CD8+ T cells co-exist during the expansion phase (Kaech and Cui,
2012). Support for this model comes from studies of stem cell-like memory T
cells (TSCM) in which cells with phenotypic and functional properties of memory
arise directly from naïve T cells upon stimulation (Restifo and Gattinoni, 2013).
Observations of cells with apparent memory properties arising in vivo after early
asymmetric division (Chang et al., 2007) or in vitro in the presence of IL-15
(Manjunath et al., 2001) or Wnt signaling agonists (Gattinoni et al., 2009)
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reinforce the notion that the genesis of T cell memory does not depend upon
transit through an effector phase, and in turn that effector differentiation is
inimical to memory potential. Alternatively, a second model holds that memory
CD8+ T cells are the progeny of cells that have differentiated into cytotoxic
effector CD8+ T cells and subsequently further differentiate to acquire memory T
cell properties following antigen clearance (Kaech and Cui, 2012). The potential
for effector cells to give rise to memory is diminished by increased or prolonged
TCR stimulation (Sarkar et al., 2008), but in any case, memory fate commitment
occurs well after effector differentiation and the resolution of infection. Lineage
tracing experiments where cells with an effector phenotype or expressing genes
reporting effector differentiation can develop into memory T cells (Jacob and
Baltimore, 1999; Opferman et al., 1999; Kaech et al., 2003; Wherry et al., 2003;
Joshi et al., 2007; Sarkar et al., 2007; Harrington et al., 2008; Bannard et al.,
2009) provide support for this model, as do functional studies that failed to
observe CD8+ T cells during the expansion phase with cardinal memory
properties of robust proliferative capacity in response to antigenic or homeostatic
signals (Kaech et al., 2002).
How to reconcile these opposing models, each with extensive support,
has been a longstanding challenge, and fundamental questions thus remain.
How is the pool of developing effector T cells maintained, and what population or
populations of cells have the potential to continue to generate new progeny
during robust infections? The data presented here may resolve some of these
questions in two ways.
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First, a highly activated yet relatively proliferatively quiescent
subpopulation of cells present early in the expansion phase is identified that
gives rise to effector CD8+ T cells. This CD62L-expressing population is
phenotypically and functionally endowed with multiple manifestations of both
stemness and memory T cell biology. While previous analyses of the expansion
phase have identified cellular heterogeneity in CD62L and KLRG1 expression
and have inferred lineage dynamics between these subpopulations based on
mathematical modeling (Buchholz et al., 2013), herein direct evidence is
presented that CD62Lhi CD8+ T cells in the expansion phase can give rise to the
full spectrum of effector subsets upon antigenic stimulation. Moreover, these
CD62Lhi CD8+ T cells are demonstrated to self-renew during the expansion
phase. This may explain why antigen-specific populations are not rapidly
depleted during vigorous expansion, and suggests a mechanism for the
generation and maintenance of responses during scenarios of persisting
antigenic stimulation, such as chronic infections or tumorigenesis.
Second, through lineage tracing experiments, the data presented here
show that the post-antigen phase pool of memory cells is seeded in part from the
stem-cell-like CD62Lhi subset present during the expansion phase, consistent
with the pre-effector model. However, in support of the post-effector model, IL7Rαhi CD8+ T cells depleted of CD62Lhi cells also appear to contribute to the pool
of long-lived central memory CD8+ T cells, which recent evidence has
unambiguously indicated to be (or be substantially comprised of) stem cells
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(Graef et al., 2014). Thus, somewhat surprisingly, this observation suggests that
long-lived, self-renewing CD8+ T cell memory can be derived not only from
developmentally and proliferatively potent CD62Lhi cells that emerge soon after
(if not at the moment of) initial activation at the inception of an adaptive immune
response, but also from CD62Llo cells that have proliferated more extensively
and undergone at least partial, antigen-driven effector differentiation, but then in
a process of apparent dedifferentiation, reacquired memory-progenitor properties
following clearance of antigen and waning inflammation.
Until quite recently, the possibility of physiological dedifferentiation was
believed to be strictly impossible in mammals. This thinking stemmed largely
from interpretations of theoretical work developed in the mid 20th century by
Conrad Waddington, the British embryologist-philosopher. Most notably,
Waddington proposed a conceptual framework that sought to explain several
fundamental observations in embryology (Waddington, 1957). Among these
were the remarkable overall consistency of development from zygote to wellapportioned neonate, despite nearly unfathomable complexity with respect to
prodigious proliferation and intertwined processes of differentiation and
morphogenesis. Despite so many trillions of possibilities for fate choices to go
spectacularly awry, they usually didn’t. How was this possible?
A related curiosity concerned apparent cellular stability: if an amorphous,
utterly undifferentiated progenitor cell could undergo the tremendous
transformations in form and function necessary to become any of the diverse
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array of highly specialized cell types that are necessary to sustain the physiology
of the mature organism – say, a rhythmically contracting cardiomyocyte or a
neuron transducing action potentials – what was to stop this transformational
process from proceeding in reverse? Surely, Waddington reasoned, there must
be some inhibitory mechanism, as chaos would undoubtedly ensue if
spontaneous changes in differentiation state were to lead cardiomyocytes to stop
pulsating or neurons to cease generating electrical impulses (Merrell and
Stanger, 2016).
To account for these phenomena, Waddington conceptualized
differentiation as a series of successive branching decisions embedded in a
three-dimensional epigenetic landscape whose contours are sculpted by the
activity of genes (Figure 2.15A). Importantly, fate commitments in development
proceeded much like a marble poised to roll down a hill to the point of lowest
local elevation. Both the consistency and irreversibility of differentiation were
functions of the increasingly steep ridges arising between the valleys of potential
that the marbles (cells and incipient tissues) traversed; when a cell reached its
position at the bottom of the hill, there was no going back uphill (Mills and
Sansom, 2015). Though first conceived as early as 1940, thus even before the
recognition of DNA as the molecular basis for heredity, Waddington’s metaphor
has become a useful and highly cited construct for thinking about the nature of
cell type identity and the formative processes that conduce to it during
development (Rajagopal and Stanger, 2016).
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As originally envisioned, Waddington’s topography exerted an inexorable
pull on developing cells and tissues – as it were, an unavoidable epigenetic
gravity. Even at the outset however, this was not interpreted in the most
absolute sense of precluding reverse differentiation in all possible scenarios. For
example, contemporaneous experiments demonstrated that mature salamander
cells could dedifferentiate and redifferentiate to regenerate amputated limbs
(Hay, 1958), and that the fate of a terminally differentiated frog genome could be
reverted to the ancestral, pluripotent state of its embryonic progenitor in the
extreme experimental scenario of nuclear transplantation (Gurdon, 1962).
Nevertheless, this observation was generally regarded as a curious exception,
one perhaps idiosyncratic to relatively short-lived amphibians. Moreover, any
conceivable dedifferentiation events in mammals, arguably more complex and
dependent upon structural consistency, were believed to be of universally
pathological import. Indeed, dating from the 19th century hypotheses of Virchow
and his student Julius Conheim, tumorigenesis has long been imagined as errant
embryogenesis (Conheim, 1875), and modern investigation has substantiated
this notion by way of the observation of cancer initiation precipitated by
dedifferentiation of lineage-committed cells into a stem-like state (Krivtsov et al.,
2006).
Given these many considerations, it was thus a significant shock when
mammalian dedifferentiation was dramatically and unambiguously reported, first
purely phenomenologically in the case of cloned sheep (Wilmut et al., 1997), and
then with mechanistic precision by way of pluripotent stem cells induced in vitro
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by defined factors (Takahashi and Yamanaka, 2006). Thus, contrary to longstanding dogma, it turns out that dedifferentiation as a general matter is possible,
including in mammals: epigenetic gravity, as envisioned in Waddington’s
topography, can be defied (Figure 2.15C). Importantly, while these extreme,
experimentally-induced cases exemplify complete loss of lineage identity and
consequent resumption of developmental pluripotency, dedifferentiation per se
need not entail traversing such drastic epigenetic distances. A formal definition
holds that “dedifferentiation refers to the reversion of a committed or
differentiated cell (defined by the expression of differentiation markers or other
features of a specialized cell) into a cell with greater developmental potential”
(Merrell and Stanger, 2016). Thus, in Drosophila gonads, both female and male
germ cells can regain stem cell identity after initiation of differentiation (Brawley
and Matunis, 2004; Kai and Spradling, 2004), while in rodents, lineagecommitted B lymphocytes can dedifferentiate into progenitor cells following
genetic manipulation in vivo, yet still retain hematopoietic character (Cobaleda et
al., 2007).
Despite these important conceptual advances, questions remain
concerning the relevance of mammalian dedifferentiation in physiological
circumstances. Recently, dedifferentiation in vivo has been reported in the
contexts of murine spermatogenesis (Nakagawa et al., 2010), intestinal epithelia
(van Es et al., 2012), pulmonary epithelia (Tata et al., 2013), and hepatocytes
(Tarlow et al., 2014). Together, these observations suggest that dedifferentiation
may play a major role in the physiology of multiple mammalian tissues and cell
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types. However, to date there have been no reports of physiological
dedifferentiation in cells of the immuno-hematopoietic lineage, though
speculation on this matter – including particularly in CD8+ T cells – has been
published (Joshi and Kaech, 2008). Furthermore, all of the aforementioned
observations source from experimentally contrived scenarios of genetic,
chemical, or physical injury. It remains unknown whether dedifferentiation can
occur spontaneously in mammals.
Thus, the observations presented in the studies herein that intermediatelydifferentiated IL-7Rαhi effector T cells (which lack robust CD62L expression) can
reacquire phenotypic (e.g. CD62L expression) and functional manifestations of
the CD62Lhi progenitor cells that developmentally precede them, are a notable
indication that dedifferentiation may play a role not only in mammalian germinal,
epithelial, and hepatic lineages, but also in immuno-hematopoietic tissue as well.
Moreover, these data provide evidence for multiple developmental origins of
memory CD8+ T cells, and thereby help reconcile the longstanding dichotomy of
the pre- and post- effector models for memory formation. Because the CD62Ldepleted IL-7Rαhi effector T cells gave rise to central memory CD8+ T cells
slightly less efficiently, these data further support a linear model of effector
differentiation with decreasing potential for memory formation. Expansion phase
CD62Lhi CD8+ T cells with minimal effector differentiation have the most per-cell
memory potential, followed by intermediately-differentiated IL-7Rαhi effector CD8+
T cells lacking CD62L expression, with the fully effector-differentiated KLRG1hi
subset contributing little to the long-term, self-renewing memory pool. Thus,
63

these data indicate a parsimonious model in which long-term central memory
sources during the expansion phase from not one but rather multiple clonal
subsets of differing extents (i.e. minimal versus extensive) of effector
differentiation (Figure 2.16).

2.7 Conclusions
Interrogating the CD62Lhi subset of CD8+ T cells during the expansion-phase of
the adaptive immune response to viral infection uncovered novel biological
features that enrich and extend our understanding of the molecular programming
and developmental sequencing underpinning the generation of memory and
effector T cells.
An abiding paradox in the field centers on the question of how activated T
cells can divide extensively and extraordinarily rapidly (Figure 1.1) – putatively
with toxic consequences for the integrity of their genomes – yet nevertheless
retain long-term viability and the potential to extensively (and rapidly) proliferate
upon subsequent encounters with pathogen-derived antigens, or upon continued
antigen presence and sustained replicative stress (e.g. in the context of chronic
microbial infections or cancers). In other tissues with intense turnover kinetics,
for example the gastrointestinal epithelium, stem cells present a solution to a
similar problem by asymmetrically dividing and thereby unequally apportioning
the burden of proliferation to downstream, transit-amplifying cells (Figure 1.2).
However the existence of stem cells and their possible relationship with the
memory T cell fate have been controversial. The data presented in this chapter
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identify a rare subset of antigen-specific CD8+ T cells during the expansion
phase that resemble somatic stem cells in other tissues, including with respect to
immunophenotype, transcriptional programming, and relative proliferative
quiescence. These features include heightened expression of protective
molecules that confer resistance to apoptosis (e.g. Bcl-2), resistance to errant
phagocytosis (e.g. CD47), and xenobiotic efflux activity. Additionally, this
CD62Lhi subset highly expressed molecules that potentiate self-renewal,
including Sca-1 and executors of the primordial Wnt signaling pathway.
Collectively, and along with the genome integrity surveillance and signal
calibration activities that are the subjects of chapters 3 and 4, respectively, these
features render CD62Lhi cells uniquely capable of withstanding the intense,
multifaceted stresses inherent in the expansion phase of adaptive immune
responses to pathogenic perturbations. In turn, these CD62Lhi cells are equipped
to subserve the evolutionarily ancient imperative of immunological memory: longterm preservation of clonal integrity to avoid selective deficiency in the repertoire
of antigen-specific lymphocytes; and to maintain the capacity for further
responsiveness to renewed or sustained encounter with antigen (Intlekofer et al.,
2006).
An additional, long-standing question in immunobiology concerns the
nature of the developmental pathways which naïve, antigen-inexperienced T
cells must traverse in order to acquire the cardinal properties of memory T cells.
To a large extent, enduring controversy about this matter has amounted to a
chicken-and-egg problem (Ahmed et al., 2009; Restifo and Gattinoni, 2013): do
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effector T cells precede memory T cells, as was first assumed by many, or do
stem-like memory T cells spawn effectors, as has more recently been
suggested? Multiple observations herein indicate support for the second view.
In particular, CD8+ T cell clonal expansion is structured according to a classical
proliferative hierarchy rooted in a rare stem/progenitor population. This CD62Lhi
population bears multiple phenotypic and functional manifestations of classicallydefined central memory, and efficiently gives rise to CD62Llo effector CD8+ T
cells. This linear, memory-to-effector differentiation pathway has been recently
corroborated by varied, largely inferential reports in the literature that
developmentally situate the memory fate prior to the effector fate on the basis of
mathematical modeling (Buchholz et al., 2013), transcriptional analyses
(Roychoudhuri et al., 2015), and epigenetic surveys (Pauken et al., 2016; ScottBrowne et al., 2016). However, the data herein also support a prominent
contribution to (at least primary) long-term cell central memory from the partiallydifferentiated IL-7Rαhi subset of effector CD8+ T cells. This observation was
surprising given traditional interpretations of Waddington’s epigenetic landscape
(Waddington, 1957) holding that effector differentiation from a stem cell
progenitor is strictly unidirectional. However, reacquisition of progenitor-fate
properties is consistent with the emerging appreciation of substantial mammalian
developmental plasticity. In the present context, CD62Llo effector T cells whose
fate is arrived at after that of CD62Lhi stem-memory-like T cells in the presence of
antigen appear to dedifferentiate into CD62Lhi long-term memory cells following
the cessation of antigen and/or inflammatory signaling. Thus, instead of
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dichotomous views maintaining that the memory fate exclusively precedes the
effector fate, or the converse, it appears that memory-like cells differentiate into
effector cells, which in turn can give rise to memory cells. As such, a subset of
effector cells (those highly expressing IL-7Rα) are simultaneously the egg and
the chicken.
Important directions of future investigation will entail substantiating this
reconciliatory ontogeny, given the caveat that developmental state in these
studies was distinguished on the basis of a single cell surface marker, i.e.
CD62L. Comprehensive transcriptional evaluation of the CD62Lhi and IL-7Rαhi
subsets – an important biological aim in its own right – may uncover additional
differential protein expression that can be used to flow cytometrically distinguish
these two subsets for more precise lineage tracing experiments. Global
epigenetic profiling can also help to define cell states and the full extent of
developmental distance between the CD62Lhi and IL-7Rαhi subsets, both in the
presence of antigen and after it has been cleared.
Beyond, a major question raised by these observations concerns any
potential differences between long-term stem/central memory T cells that derive
from cells that always manifested a stem/progenitor fate (e.g. the CD62Lhi
subset) versus those that arise consequent to dedifferentiation from partially
differentiated IL-7Rαhi effector cells (Figure 2.16). As one prominent Drosophila
biologist has put it, is there any difference between counterfeit and original stem
cells (Spradling and Fan, 2010)? Given the very different histories of proliferation
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and deployment of various protective programs between these two expansion
phase T cell subsets, one might indeed expect substantial differences (Mills and
Sansom, 2015), which in turn could be of functional consequence for the overall
capacity of long-term T cell memory. Consistent with this expectation is the
observation that IL-7Rαhi cells, in stark contrast to CD62Lhi cells, were almost
bereft of ability to persist in conditions of enduring replicative stress (Figure 2.13).
Nevertheless, future work will need to probe this matter empirically, as well as
the related matter of these two populations’ relative contributions to both primary
and secondary long-term (i.e. “central”) memory formation. At present, the
studies presented herein clarify the developmental origins of CD8+ T cell memory
and point to novel opportunities to further dissect the molecular basis of
immunological memory and progenitor cell biology.
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Figure 2.1: Efflux activity during the CD8+ T cell response to viral infection
enriches for expression of CD62L. Splenocytes from mice d6 pi LCMV-Armstrong
were incubated in Hoechst 33342 for 90 minutes at 37° C and then counter-stained with
fluorescently-labeled antibodies against surface markers. Simultaneous, dualwavelength visualization of Hoechst 33342 fluorescence in CD8+ T cells revealed an
actively effluxing, so-called “side population” (left). Analysis of CD62L expression (right)
in the side population (blue histogram) versus all remaining, non-effluxing cells (gray
histogram) revealed a marked enrichment in the former.
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Figure 2.2
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Figure 2.2: An antigen-specific, central memory-like CD62Lhi CD27hi subpopulation
exists during the antiviral expansion phase and is enriched within the KLRG1lo IL7Rαhi population. Bivariate plots of flow cytometric data depict the immunophenotypes
of splenocytes harvested at d8 pi LCMV-Armstrong from CD45.2+ C57Bl/6 mice that had
been transplanted prior to infection with CD45.1+ LCMV-specific P14 TCR-transgenic
CD8+ T cells. The CD45.1+ P14 population of antigen specific cells is identified at the
top-left, and then sub-fractionated by various markers. Of particular note is the KLRG1lo
IL-7Rαhi CD62Lhi CD27hi sub-population (bottom right). Numbers denote frequency
within the gated population.
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Figure 2.3: Presence of a CD62Lhi KLRG1lo IL-7Rαhi subset in antigen-specific CD8+
T cells during the expansion phase of bacterial and viral infections. A) C57Bl/6
mice received 5,000 congenically disparate P14 TCR-transgenic CD8+ T cells and then
were infected intravenously with Listeria monocytogenes expressing the LCMV gp33
epitope (LM-gp33). The presence of the three expansion phase subsets of CD8+ T cells
was determined for responding P14 cells by flow cytometry at d8 pi. B) C57Bl/6 mice
received 50,000 congenically disparate OT-I TCR-transgenic CD8+ T cells and then
were infected intravenously with vesicular stomatitis virus (VSV) expressing OVA (VSVOVA). The presence of expansion phase subsets of CD8+ T cells was determined for
responding OT-1 cells by flow cytometry at d8 pi.
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Figure 2.4: Presence of a CD62Lhi KLRG1lo IL-7Rαhi subset in endogenous,
antigen-specific CD8+ T cells during the expansion phase of the adaptive immune
response to LCMV infection. C57Bl/6 mice were infected with LCMV-Armstrong. At
d8 pi, splenocytes were stained with peptide-MHC tetramers to detect CD8+ T cell
populations specific for the subdominant DbGP276 (A) and DbGP33 (B) epitopes, and
the dominant DbNP396 epitope (C).
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Figure 2.5: Immunophenotypic characterization of the antigen-specific CD62Lhi
population during the expansion phase of acute viral infection. Subsets of GP33specific splenocytes were flow-cytometrically evaluated at d8 pi LCMV-Armstrong for
expression of the factors implicated in the activation and differentiation of CD8+ T cells.
A) Histograms depicting expression of markers implicated in lymphocyte stemness (left),
and of transcription factors associated with memory vs. effector fate decisions. B)
Expression of cytokines after ex vivo restimulation with GP33 peptide in the presence of
100 μM TAPI-2 in LCMV-specific CD8+ T cell subsets (indicated in blue, green, and red)
and polyclonal naïve CD8+ T cells (indicated in grey). C) Expression of Granzyme B in
LCMV-specific CD8+ T cell subsets and polyclonal naïve cells. D) Heatmap depicting
relative protein expression determined by flow cytometry for indicated markers; red
indicates higher expression, while blue indicates lower expression.
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spleen, n=3, gated on CD8+ CD45.1+ P14s (except naive population); error bars denote SEM
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Figure 2.8: Proliferative index, proliferative history, and absolute abundance
suggest expansion phase, antigen-specific CD8+ T lymphocyte subsets may be
structured in a proliferative hierarchy. A-B: Proliferative history of P14 CD8+ T cells
and subsets thereof under conditions of physiological and supraphysiological naïve
precursor numbers. A) C57Bl/6 mice received physiological (2 x 103, top panels) or
supraphysiological (2 x 106, bottom panels) numbers of proliferation-dye-labeled P14
cells, and were then infected with LCMV-Armstrong. At d8 pi, proliferation dye dilution
was measured by flow cytometry in donor P14 cells in the spleen. Dye dilution is
depicted in total P14 populations (large, upper panels) and in the CD62Lhi, IL-7Rαhi and
+, n=5
d8 pi LCMV-Arm,
splenocytes gated
on CD8+ CD45.1of
KILRG1hi subsets (smaller, lower panels).
B) Statistical
summary
the data in part A.
Asterisks indicate statistical significance (p < 0.05) determined by one-way analysis of
variance (ANOVA). Error bars depict mean ± SEM. C) Proliferative index analyzed at
the end of the expansion phase. Top: Mice containing P14 cells were pulsed with BrdU
at d7 pi and BrdU incorporation in the three LCMV-specific CD8+ T cell subsets (and
naïve CD8 T cells) was assessed at d8 pi. Middle: Ki-67 expression was examined at
d8 pi in the three subsets and in naïve CD8+ T cells. Bottom: Expression of the cell
cycle reporter Fucci-mAG was assessed in the three subsets indicated. D) Abundance
of cells in each of the three LCMV-specific subsets at d8 pi in the spleen.

2014.04.06

76

Figure 2.9
MTG MFI (WT P14s)
1000

A
MTG MFI
MTG
(MFI)

800

600

400

200

TE

SC

T

T

N

ai

ve

<FITC-A>: MTG 50nM

M
P

0

MTG

Rapamycin Treatment Increases TSC Abundance

C
GP33+ CD62Lhi KLRG1lo IL-7Rαhi (# of cells per million)

B
<APC-Cy7-A>: CD27

7.29
7.3

PBS

<PE-Cy7-A>: CD62L

JJA404

<APC-Cy7-A>: CD27

11.1
11.1

R 75

<PE-Cy7-A>: CD62L

<APC-Cy7-A>: CD27

25.6
25.6

7.29
7.3

*

4×10 5

d8 pi LCMV-Arm; spleen; n=3; gated on CD8+ WT-P14+

3×10 5

2×10 5

1×10 5

0

PBS

R 75

R 300

co
nt
ro
l(
PB
S)
R
ap
a
75
µg
/k
R
g
ap
a
30
0
µg
/k
g

<PE-Cy7-A>: CD62L

CD62L

<APC-Cy7-A>: CD27

CD27

R 300

*

5×10 5

<PE-Cy7-A>: CD62L

<PE-Cy7-A>: CD62L

<PE-Cy7-A>: CD62L

2014.03.23 (further-analyzed 2015.03.20)

<APC-Cy7-A>: CD27

<APC-Cy7-A>: CD27

<APC-Cy7-A>: CD27

<PE-Cy7-A>: CD62L

<APC-Cy7-A>: CD27

<APC-Cy7-A>: CD27

Figure 2.9: Mitochondrial-biased metabolism characterizes and drives abundance
11.1
11.1
of the CD62Lhi subset. A) Measurement
of mitochondrial mass by way of MTG
(mitotracker-green) fluorescence in naïve CD8+ Tcontrol
cells(PBS)
and subsets
P14 splenocytes
Rapa of
75 µg/kg
Rapa 300 µg/kg
isolated at d8 pi LCMV-Armstrong. B-C: Treatment with increasing doses of Rapamycin
progressively increases the relative and absolute abundance of the CD62Lhi subset. In
7.29
11.1
25.6
7.3of PBS or Rapamycin
11.1
25.6
this experiment, mice were treated with daily injections
at 75 μg/kg
or 300 μg/kg following infection with LCMV-Armstrong. At d8 pi, PBMC were evaluated
25.6 subsets. Flow cytometry plots in B) depict CD62L
25.6
for the abundance of antigen-specific
and CD27 expression within the GP33+ KLRG1lo IL-7Rαhi compartment; C) statistically
depicts the abundance of GP33+ CD62Lhi KLRG1lo IL-7Rαhi cells (i.e. the CD62Lhi
CD62L
subset).
<PE-Cy7-A>: CD62L

<PE-Cy7-A>: CD62L

77

PBMC, d8 pi LCMV-Arm; flow plots gated on CD8+ GP33+ KLRG1lo CD1

Figure 2.10
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Figure 2.10: Self-renewal and lineage relationships of expansion phase LCMVspecific CD8+ T cell subsets. A) Schematic of experimental design to determine
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Figure 2.11: Lineage relationships between expansion-phase and post-antigenphase subsets. A) Experimental design: splenic P14 subsets were sorted at d8 pi (B,
left) and transplanted into congenically disparate naïve recipient mice. After 6 months,
the frequency of donor cells with a CD62Lhi “central memory” phenotype was determined
in recipient spleens (B, right flow cytometry plot and bar graph). C) Experimental
design: CD62Lhi, IL-7Rαhi and KLRG1hi P14 subsets were sorted at d8 pi LCMV and
proliferation dye-labeled. After mixing with congenically disparate, proliferation dyelabeled OT-I naïve CD8+ T cells as a control, sorted P14 cells of each subset were then
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immunophenotype (D) and extent of proliferation dye dilution (E) of donor cells were
evaluated in recipient mouse spleens (orange histograms denote P14 cells, grey
histograms denote control, co-transplanted naïve OT-I cells).
CXCR3

IL-7Rα

CD62L

JBJ458

79

Figure 2.12

F

d8 pi,
30d
7d
Sort subsets,
Challenge
Analyze
Expansion Capacity Upon Cl-13 Rechallenge
Expansion Capacity Upon Cl-13 Rechallenge
transfer
7

6

+

4

3

+

<PE-TxRed-A>: CD8

0.1

2

1

4×105

3×105

2×105

1×105

0

BA

SC

T

+
lo
hi
hi (% of P14)
CD62L
CD62L+KLRG1
KLRG1lo CD44hiCD44
CD27+ (% ofCD27
donor P14 population)

SC

T

TE

0

<PE-TxRed-A>: CD8

CD8

M
P

<Pacific Blue-A>: CD45_1

CD45.1

0.101

5×105

TE

2.6

5

*

M
P

2.6

*

6×105

+

<PE-TxRed-A>: CD8

<Pacific Blue-A>: CD45_1

*

of CD45.1 donor P14 cells per spleen
# #of
donor P14 cells/spl

CD45.1 Donor P14s (% of CD8 )
donor
P14s (% of CD8+)

<Pacific Blue-A>: CD45_1

5.9

7×105

*

5.91

(Re)Generation of CD62L+ Population

87
12.5
13
87.1

1.2
1.2
0.273
0.3

<FITC-A>: KLRG1

87
59

81
80.6

<PE-A>: CD27

<E Fluor 605-A>: CD62L

<AF 700-A>: CD44

100
100

40

0.1
0.139

40

CD62L
<E Fluor 605-A>: CD62L

CD44

<FITC-A>: KLRG1

KLRG1

<PE-A>: CD27

0.5
0.468
0.627
0.6

86.7

59.2

1.5

*
*

[2016.03.23 re-analysis]
pi Cl-13
A-pop
xfer#2, 2013.05.08
d7 pi Cl-13
rechallenge,
n=5 per group (TSC, MP) or 4 perd7
group
(TE)rechallenge, n=5 per group (TSC, MP) or 4 per group (TE)

<AF 700-A>: CD44

<E Fluor 605-A>: CD62L

<AF 700-A>: CD44

[2016.03.23 re-analysis]
A-pop xfer#2, 2013.05.08

92
91.6

CD27
<PE-A>: CD27

1.0

0.5

0.0

TE

1.1

<FITC-A>: KLRG1

11

M
P

1.09

SC

10.6

T

A

.
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Figure 2.14: Phenotypic and functional differences between CD62Lhi subsets
during the antigen-driven expansion phase and the post-antigen phase. A-C)
PBMC were isolated from mice at d8 pi and > 2 months pi LCMV-Arm and stained
separately with anti-CD8α conjugated to distinct fluorophors. Following CD8α staining,
samples were combined and stained together for CCR7, CD43, congenic marker (to
identify P14 cells), and lineage markers. CD62L expression was examined within the
KLRG1lo IL-7Rαhi progenitor compartment (gated on LCMV-specific cells) at 8 days and
> 2 months pi, and depicted as bivariate plots in (A) and as overlaid histograms in (B).
C) Expression of CCR7 (left), CD43 (middle), and PD-1 (right) on polyclonal naïve cells
(grey), and LCMV-specific CD62Lhi KLRG1lo IL-7Rαhi cells at 8 days pi (light blue) and >
2 months pi (dark blue). D) Phosphorylation of H2AX following ex vivo irradiation was
assessed as in Fig 3C, and is here depicted as the capacity of LCMV-specific CD62Lhi
KLRG1lo IL-7Rαhi cells to phosphorylate H2AX relative to that of polyclonal naïve cells.

83

Figure 2.15
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Figure 2.15: Differentiation and Dedifferentiation. A-B) Differentiation entails
traversing an epigenetic landscape, as originally conceptualized by Conrad Waddington,
with concomitant acquisition of specialized form and function. In this schematic
“progenitor” cells correspond to the CD62Lhi subset of antigen-specific CD8+ T cells;
“differentiating cells” correspond to the IL-7Rαhi subset; and “differentiated cells”
correspond to the KLRG1hi subset discussed in the text. C) Though cellular
specialization was believed to be unidirectional, convincing data in amphibians and more
recently in mammals has demonstrated that differentiated cells can partially or entirely
revert to or assume the undifferentiated state of their progenitors. Adapted from
Waddington, C.H. The Strategy of the Genes: a Discussion of Some Aspects of
Theoretical Biology. London: Allen & Unwin, 1957. Reproduced with permission from
Merrell AJ and Stanger BZ. Adult cell plasticity in vivo: de-differentiation and
transdifferentiation are back in style. Nat Rev Mol Cell Biol. 2016 Jul; 17(7):413-25.
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Figure 2.16: Model for stem-cell-driven effector T cell differentiation in the
presence of antigen and subsequent dedifferentiation into memory T cells in the
absence of antigen. A naïve T cell is activated by encounter with cognate antigen in the
context of immunological danger and gives rise to a clonal stem cell hierarchy marked by
increasing proliferation, and progressive cytotoxic effector differentiation. Following
antigen elimination and the resolution of acute infection, terminally-differentiated effector
cells (red) largely commit to apoptosis, whereas intermediately effector-differentiated
memory precursor cells (green) gradually reacquire the stemness of their progenitors
(blue). In the post-antigen phase, the pool of memory T cells, composed of TSC and TSC’
populations, is heterogeneous with respect to proliferative past and history of effector
differentiation.
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.:: CHAPTER 3 ::.
SPECIALIZED FUNCTION FOR T STEM CELLS IN CONSERVING
GENOME INTEGRITY; IMPLICATIONS FOR AGING CLOCKS
3.1 Genome integrity maintenance and the stem cell theory of aging
DNA damage is an ongoing, daily occurrence with which all cells must contend.
For example, it’s been estimated that the average cell experiences roughly
100,000 spontaneous DNA lesions per day (Lindahl, 1993). While damage to
any of the structures that constitute the cell — e.g. lipid membranes, RNA
species, proteins, cytoskeletal components, various macromolecular machines
and organelles, — can threaten viability and as such must be addressed, if repair
is not practical, outright replacement is always a possibility, assuming energy and
raw building blocks are available to support de novo synthesis. In contrast,
because chromatin is the ultimate repository for the information that templates all
other cellular structures, any injuries thereto can be uniquely pernicious. In
parallel to cosmological considerations about the nature of black holes, mere
matter can always be retrieved, recycled, or rebuilt, as necessary; however, once
lost, information is gone forever. As such all nucleated cells in all known species
deploy multitudinous, complementary surveillance and repair mechanisms to
minimize genomic damage (Blanpain et al., 2011). The fidelity of maintenance
and repair activities is incomplete, however, and numerous datasets across
multiple species indicate that errors occur, accumulate, and gradually diminish
genome integrity over time (Herbig et al., 2006; Lopez-Otin et al., 2013).
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The idea that declining genome integrity might be involved in the aging
process has been pondered for decades. But is this merely one of the many
curious features of aging, or is it actually important? Though cause and effect
relationships concerning information maintenance can be exceedingly difficult to
discern, there is growing support for the notion that declining genome integrity
not only accompanies the aging process at the cellular and organismal levels, it
also drives it. This is perhaps most dramatically evident in the progeroid
syndromes that manifest in both model organism systems and humans
consequent to mutations in factors involved in genome maintenance (de Boer et
al., 2002; Kujoth et al., 2005; Burtner and Kennedy, 2010). Moreover, while
inactivation of genome maintenance factors abbreviates lifespan in multiple
species with broadly varying lifespans, genetic analyses have indicated that a
major determinant of the lifespan differences between species is the extent or
nature of the activity of DNA damage surveillance and repair factors (Lorenzini et
al., 2009; Ma et al., 2016). Thus, with respect to the aging process, genomic
information is vitally important: corruption thereof causally leads either to loss-offunction or hyperplastic gain-of-function, and almost invariably to decreased
fitness and an earlier ultimate demise.
However, developmental biologists have long appreciated that most of the
cells that constitute a metazoan soma over a lifetime have a finite, often very
limited lifespan, and are replenished from self-renewing stem cell compartments,
either continuously or in injury-regeneration scenarios. As such, while all
nucleated cells must monitor and sustain chromatin fidelity to some extent, an
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extensive body of theoretical writing and more limited empirical evidence suggest
that stem cells may be particularly important for and invested in the genome
maintenance and repair activities that ultimately are most proximally related to
organismal aging (Cairns, 1975; Blanpain et al., 2011). Together, these notions
constitute the so-called stem cell theory of aging, which holds that stem cells
have a prominent, perhaps predominant role in conserving overall, organismal
genome integrity; and that the accumulation of genomic and epigenomic
mutations that nevertheless inevitably accumulate in stem cells ultimately
diminishes their function and thereby hastens organismal death (Krishnamurthy
and Sharpless, 2007; Brunauer et al., 2015). In this chapter, this hypothesis is
probed with respect to T stem cells. Is genomic integrity relevant to the functions
of anti-pathogen T cells? Do T stem cells resemble other stem cell populations in
terms of specialized functions with respect to genomic integrity conservation?
Can analysis of genome integrity in T cells, which replicate uniquely rapidly, in
turn inform understanding of stem cell biology more generally?

3.2 Superior surveillance of genome integrity in T stem cells
The observations presented in the previous chapter revealed the existence of a
quantitatively minor subset of cells in the anti-viral T cell expansion phase with
unique developmental features, including robust yet restrained proliferation,
substantial efflux activity, and a protein expression profile that intersects with that
of stem and progenitor cells in other developmental contexts. In many biological
systems there is a known (if little understood) association between progenitor
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cells in proliferative hierarchies and the maintenance of genomic integrity (Flores
et al., 2008). Analysis of global gene expression in unfractionated, antigenspecific CD8+ T cells isolated at various time points before, during, and after an
acutely-resolving viral infection indicated that the cellular DNA damage response
machinery is highly dynamically regulated (Figure 3.1). This offered an initial
indication that DNA damage and/or the response thereto is likely to be important
in the lives of CD8+ T cells responding to pathogenic perturbations, and provided
the impetus to specifically interrogate this issue in the three expansion phase
subsets of CD8+ T cells first described in the prior chapter.
To begin to assess DNA damage in the three subsets, the alkaline comet
assay (Olive and Banáth, 2006) was employed to directly measure DNA breaks.
This approach clearly revealed increased tail moments indicative of DNA
damage in the KLRG1hi subset, while both the IL-7Rαhi and CD62Lhi subsets
exhibited lower tail moments (Figure 3.2). While these data suggested that
terminal differentiation may be associated with loss of genome integrity, the
resolution of this assay was insufficient to discern whether differences existed in
the IL-7Rαhi and CD62Lhi subsets. An alternative approach was called for. A
major mechanism by which cells monitor DNA damage operates through
phosphorylation of the variant histone H2AX, which in turn leads to the
recruitment of DNA repair machinery (Bonner et al., 2008). Therefore H2AX
phosphorylation was measured directly ex vivo during the effector phase. The IL7Rαhi subset of LCMV-specific CD8+ T cells displayed slightly lower pH2AX
relative to naïve CD8+ T cells, while pH2AX was even lower in the KLRG1hi
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subset, suggesting diminished efficiency of DNA strand break surveillance in this
terminally-differentiated subset. In contrast, H2AX phosphorylation was
markedly elevated in the LCMV-specific CD62Lhi subset, with ex vivo pH2AX
expression 24% greater than naïve CD8+ T cells and 41% greater than observed
in the IL-7Rαhi subset (Figure 3.3A). These data suggested the CD62Lhi subset
was characterized by either greater DNA damage or enhanced surveillance of
genome integrity. To test whether these differences reflected the ability of cells
to respond to experimentally induced DNA strand breaks, each subset and
control naïve CD8+ T cells were exposed to equal amounts of DNA damage
using controlled ionizing irradiation ex vivo at a dose known to affect progenitor
cell biology (Mohrin et al., 2010). While all subsets upregulated H2AX
phosphorylation following irradiation, the extent of induction in IL-7Rαhi and
KLRG1hi effector subsets was lower than that of naïve CD8+ T cells (Figure
3.3B). In contrast, the CD62Lhi subset was substantially more efficient in
initiating the H2AX-mediated DNA damage response pathway compared to naïve
CD8+ T cells or compared to either of the two CD62Llo effector CD8+ T cell
subsets (Figure 3.3B); the CD62Lhi subset was ~33-100% more efficient than
the other subsets of CD8+ T cells examined (Figure 3.3B, right panel). These
results suggested that the CD62Lhi subset may be preferentially endowed with
the ability to surveil and respond to DNA damage, while the IL-7Rαhi and
KLRG1hi effector subsets may be disadvantaged in this respect.
Interestingly, the Wnt signaling pathway has been implicated in the
regulation of genome maintenance activities (Kendziorra et al., 2011; Hoffmeyer
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et al., 2012), and the data reported in the prior chapter indicated that TCF-1, a
principal transcriptional effector of transduced Wnt signals, is preferentially
expressed in the CD62Lhi subset relative to the CD62Llo subsets (Figures 2.5A
and 2.5D). To probe whether a causal relationship existed between TCF-1
expression and heightened responsiveness to DNA damage, TCR-transgenic
P14 CD8+ T cells conditionally deficient for TCF-1 (by virtue of CD4-Cre
expression in thymocyte precursors driving excision of a floxed TCF-1 allele)
were generated, transplanted into naïve recipient mice, and assessed for their
ability to phosphorylate H2AX 8 days pi LCMV. Relative to WT controls, cells in
the TCF-1-deficient CD62Lhi subset (but not the IL-7Rαhi or KLRG1hi subsets)
exhibited diminished basal pH2AX expression (Figure 3.4). Unexpectedly, no
difference was observed in the ability of cKO vs. WT CD62Lhi CD8+ T cells to
upregulate H2AX phosphorylation following ex vivo irradiation. This may be due
to contamination of the putative cKO fraction by cells bearing the Cre and floxed
target allele genotype that nevertheless escaped phenotypic excision and
deletion of TCF-1 as a consequence of the known incomplete efficiency of the
CD4-Cre driver utilized in these experiments. In any event, there does appear to
be a causal relationship between TCF-1 expression and H2AX phosphorylation,
to some extent. The full import of this should be explored in future experiments
that exploit more efficient Cre driver alleles or fluorescent-reporter strategies to
exclude false-positive cells that have not completely excised their TCF-1 alleles.
To further interrogate pathways of genome maintenance, telomerase
activity was examined in antigen-specific CD8+ T cell subsets during the
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expansion phase. After sort-purifying CD62Lhi, IL-7Rαhi, and KLRG1hi subsets,
telomerase holoenzyme activity was assessed. The CD62Lhi subset exhibited
markedly higher telomerase activity than either naïve CD8+ T cells or the CD62Llo
effector subsets (Figure 3.5). This elevated telomerase activity suggests that the
CD62Lhi subset acquires multiple genome surveillance and maintenance
activities following initial activation of naïve precursors.
The data above suggested that the CD62Lhi subset was endowed with
greater capacity to withstand and/or respond to DNA damage. To directly
interrogate this question in vivo, a genome integrity disruption assay was
designed. Mice were infected with LCMV and exposed to the DNA damaging
agent doxorubicin during the expansion phase at a time point – d6 pi – when all
three LCMV-specific subsets are robustly dividing. Doxorubicin exposure
dampened the expansion of responding LCMV-specific CD8+ T cells in a dosedependent manner (Figure 3.6A, bottom), and quantitatively impacted all three
subsets. The KLRG1hi subset was markedly diminished and the IL-7Rαhi subset
was modestly enriched (Figure 3.6B). In contrast, the CD62Lhi subset was
preferentially resistant to doxorubicin exposure (Figure 3.6B). Though the
precise mechanism is unclear, this result is consistent with the restrained
proliferation of the CD62Lhi subset, its substantial efflux activity, and its superior
capacity to respond to DNA damage induced by ionizing irradiation ex vivo.
Together these observations point to genome integrity surveillance and
maintenance as key properties necessary for a robust CD8+ T cell response to
infection, and particularly for the generation or survival of the CD62Lhi subset.
92

3.3 Retrotransposon dynamics during T stem cell and T effector
differentiation
First discovered by Barbara McClintock in the 1940’s, jumping genes or
transposable/mobile elements are important players in evolution (McClintock,
1950) and comprise an enormous proportion of mammalian genomes – around
40%, depending on species (Bodak et al., 2014). Among transposable elements,
LINE-1’s (long interspersed nuclear element 1, hereafter L1) are particularly
abundant and the most well-studied. L1 loci span 6 kilobases and contain a 5’
untranslated region with internal promoter activity, and two non-overlapping
ORFs encoding a chaperone / RNA binding protein and an endonuclease /
reverse transcriptase. Roughly 500,000 L1 copies stud the (human) genome,
comprising about 17% of its total, while 600,000 L1 copies amount to 19% of the
mouse genome (Bodak et al., 2014). The passage of time since the initial
infection and integration into the germline millions of years ago has mutated the
vast majority beyond any semblance of retrotranspositional competence;
however roughly 0.02-0.5% of L1 loci have retained the capacity for expression
and quasi-random genomic reintegration, and are termed “hot”. Copy-and-paste
retrotransposition can be highly genotoxic if integration events disrupt function at
a critical locus or introduce gain-of-function mutations in an oncogene, and
indeed seminal studies have recently implicated L1 activity in the aging process
(Li et al., 2013) and a substantial percentage of human cancers (Lee et al., 2012;
Shukla et al., 2013; Ewing et al., 2015). Because of these deleterious
consequences, with rare exceptions (Kano et al., 2009), mammalian tissues
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normally suppress hot L1 loci. However, recent observations indicate that
transient derepression may occur consequent to cell division (Abyzov et al.,
2013) or epigenetic remodeling (Klawitter et al., 2016). Given that activated CD8+
T cells divide rapidly and extensively (cf. Figure 1.1), and undergo substantial
epigenetic transformations during effector differentiation (Pauken et al., 2016;
Scott-Browne et al., 2016), it seemed reasonable to wonder whether L1
expression, normally tightly controlled, might be perturbed in these cells.
3.3.1 Mobilome matters: effector T cell differentiation is associated with
derepression of the ancient retrotransposon LINE-1
LINE-1 RNA abundance was measured in naive CD8+ T cells and in the three
antigen-specific CD8+ T cell subpopulations present during the expansion phase
of the adaptive immune system’s response to viral infection. Naive cells
manifested only background LINE-1 levels. In contrast, activated, antigenspecific cells exhibited upregulation of LINE-1, with modest levels in minimallydifferentiated T stem cells, intermediate quantities in intermediately-differentiated
effector cells, and heightened levels in terminally-differentiated effector cells
(Figure 3.7, right). Interestingly, preliminary experiments indicated that this
pattern of LINE-1 re-expression correlating with effector T cell differentiation
manifested at both the RNA and DNA levels, suggesting that the dormant L1
transposon is not only re-expressed at the RNA level, but also continues its
lifecycle to make protein and reverse transcribe its RNA genome into DNA.
Given that reverse transcription is usually known to occur in the nucleus via a
process termed target-primed retrotransposition (Gorbunova et al., 2014), it is
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very likely that at least some of this DNA is being integrated into the nuclear
genome. Irrespective of future experiments to test this hypothesis directly, this
finding of effector T cell differentiation associated with transposon re-expression
has implications for basic principles of genome integrity maintenance and
developmental biology. Additionally, these observations may also serve as
platform for several useful experimental and clinical applications including highly
tractable lineage tracing in vivo and an irreversible, granular biological clock to
report physiological as opposed to chronological age.

3.3.2 Heightened expression of the antiretroviral cytidine deaminase
Apobec3 in T stem cells
To preserve genome integrity against the existential threat of mutagenic
transposition, mammalian cells mount a variety of defenses to suppress
expression of jumping genes, perhaps most prominently the retroelement
restriction factor Apobec3 (Esnault et al., 2005; Muckenfuss et al., 2006). Given
that T stem cells preferentially express multiple genome integrity maintenance
activities including telomerase and heightened DSB surveillance, and considering
the genotoxic threat posed by endogenous retroelements, it is reasonable to
hypothesize that expression of Apobec3 might be an additional mechanism by
which CD62Lhi T stem cells maintain genome integrity. Thus, expression was
evaluated at the RNA level in naive CD8+ T cells and in the three principal
antigen-specific CD8+ T cell subpopulations present during the expansion phase
of the adaptive immune system’s response to viral infection. Apobec3
expression was negligible in naive CD8+ T cells but markedly upregulated in T
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stem cells, and sharply diminished in differentiated, CD62Llo effector CD8+ T cells
(Figure 3.7, left). It is notable that within the three principal antigen-specific
CD8+ T cell subpopulations, this expression pattern of Apobec3 is exactly the
inverse of that of LINE-1 (described above). While a role for Apobec3 in
restricting LINE-1 expression has been published in vitro, to date no evidence for
this has been uncovered in vivo. Together, these observations of Apobec3 and
L1 expression lead to the hypothesis, testable in future work making use of
Apobec3-deficient T cells, that the former has a causal role in regulating the latter
in vivo, quite possibly in the service of preventing L1 retrotransposition and
consequent diminished genome integrity. Additional experimentation should
address whether there are any consequences to CD8+ T cell function arising
from unrestrained retrotransposition.

3.4 Conclusions
One of the more distinguishing features of these expansion phase CD62Lhi CD8+
T cells was the stark upregulation of genome maintenance pathways, as
evidenced by a superior anticipatory response to irradiation-induced DNA
damage, a marked increase in telomerase activity, and elevated expression of
the retrotransposon restriction factor Apobec3a. One suggestion about stem-like
memory T cells arising early after stimulation is that such cells simply remain
more naïve-like and by remaining less differentiated thereby maintain better
memory potential. While the CD62Lhi expansion-phase CD8+ T cells studied here
are indeed more proliferatively quiescent and restrained with respect to the
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elaboration of a full effector gene expression program, upregulation of genome
integrity surveillance is a major change distinguishing these cells from naïve or
subsets of CD62Llo effector CD8+ T cells. Thus, this CD62Lhi subset does not
simply remain less differentiated. Instead, this population acquires a markedly
different pattern of differentiation compared to naïve, IL-7Rαhi or KLRG1hi cells.
Proliferative hierarchies subserve tissue homeostasis in many settings of rapid
cellular turnover including hematopoiesis and epithelial barrier maintenance
(Weissman, 2000; Simons and Clevers, 2011) and such proliferative hierarchies
have been previously implicated in effector CD8+ T cell generation (Sarkar et al.,
2008; Buchholz et al., 2013; Gerlach et al, 2013). The data presented here now
provide mechanistic understanding for a key feature of this proliferative hierarchy
in CD8+ T cells in the induction of a genome integrity maintenance circuit. With
antigen-driven CD8+ T cells dividing as fast as once every 4 hours during the
expansion phase, it is likely that much of the genomic damage that occurs is due
to replication fork errors and/or chromosomal segregation. It is interesting that in
other cell types slowing cell division time by as little as 20 minutes can be
sufficient to allow repair of genomic instability and damage (Sansregret et al.,
2017). In this respect, while the CD62Lhi subset has divided extensively, its
slower cell division rate may be an additional feature of the genome integrityprotective module deployed by these cells. Future studies should evaluate the
implications of different types of genomic stress on these cells. A model is
presented in which the lineage relationships elucidated in the prior chapter are
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correlated with the genome integrity status inferred from the data presented in
the present chapter (Figure 3.8).

98

Figure 3.1
Naïve d6

d8

d15 d30

Figure 3.1: Dynamic regulation of DNA damage response circuitry during antiviral
CD8+ T cell proliferation & differentiation. The gene ontology term “DNA damage”
was used to construct a set of genes associated with DNA damage; transcript levels of
these genes, as measured by oligonucleotide microarrays, were then clustered
according to the similarity of their transcriptional regulation in antigen-specific CD8+ T
cells responding to acute viral infection. Splenic T cells were profiled in naïve mice, and
days 6, 8, 15, and 30 post infection with LCMV-Armstrong (as detailed in Crawford et al.,
2014). Each row represents a transcript, and each column represents data from a single
microarray; there are three or four replicates per time point. It is evident that the
transcriptional response to DNA damage is dynamically regulated in CD8+ T cells over
the course of their response to infection.
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Figure 3.2: Elevated DNA damage in terminally-differentiated, antigen-specific
CD8+ T cells. Alkaline comet assays indicating extent of chromatin disintegration were
performed for sorted subsets of splenic,
antigen-specific
CD8+ T cells isolated at d8 pi
2013.05.09
comet
assay
#2
LCMV-Armstrong. Naïve CD8+ T cells were used as a negative control; naïve CD8+ T
cells exposed ex vivo to 250 rads of ionizing irradiation served as a positive control.
Representative microscopic images of negative control and positive control cells are
inlaid.
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Figure 3.3: Elevated basal and DNA damage-inducible H2AX phosphorylation in
antigen-specific T stem cells. A) Basal phosphorylation of H2AX measured directly ex
vivo in the indicated LCMV-specific CD8+ T cell subsets isolated at d8 pi LCMVArmstrong or naïve CD8+ T cells. C) Damage-induced phosphorylation of H2AX in the
indicated LCMV-specific CD8+ T cell subsets isolated at d8 pi LCMV-Armstrong or naïve
CD8+ T cells. Cells were exposed to 250 rads of ionizing radiation ex vivo and then
incubated at 37°C for 90 minutes. Histograms (left) depict the extent of basal (black
lines) and irradiation-induced (red lines) pH2AX. Bar graph depicts the inducibility of
pH2AX, calculated as the difference between the basal and irradiation-induced values.
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Figure 3.4: Diminished basal H2AX phosphorylation in TCF1-deficient T stem
cells. Differentially congenic WT P14 CD8+ T cells and P14 CD8+ T cells conditionally
homozygously deficient for TCF-1 were mixed in a 1:1 ratio and co-transplanted into
naïve recipient mice. Following infection with LCMV-Armstrong, splenocytes were
obtained at d8 pi and evaluated flow cytometrically for phosphorylation of the variant
hi
d8 pi LCMV-Arm; spleen;
5K CD4Cre+subset
TCF1WT and
5K CD4Cre+ TCF1fl/fl P14s; n=10
JBJ465 H2AX on antigen-specific
histone
WT mice
andreceived
cKO CD62L
cells.

102

Figure 3.5
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Figure 3.5: Elevated telomerase activity in antigen-specific T stem cells during
viral infection. Telomerase activity was assessed by QTRAP assay (see methods) for
the indicated splenic LCMV-specific CD8+ T cell subsets isolated at d8 pi LCMVArmstrong or naïve CD8+ T cells. Heat-inactivated 293T cells were used as a negative
control.
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2012.12.23: d8-LCMV.Arm after d5.5 Doxorubicin treatment

Figure 3.6
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Endogenous Retrovirus Expression with
Elevated Expression of Apobec3 mRNARelaxed
in
Progressive antiviral CD8+ T cell Differentiation
Virus-specific CD8+ T Stem Cells

Figure 3.7
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Figure 3.7: Elevated expression of the retroelement restriction factor Apobec3 in
antigen-specific T stem cells correlates with relaxed suppression of the ancient
retrotransposon LINE-1 during antiviral CD8+ T cell differentiation. RNA isolated
from subsets of P14 splenocytes sorted at 8 pi LCMV-Armstrong was used for qPCR
analysis of the abundance of Apobec3 and LINE-1 mRNA.
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Figure 3.8
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Figure 3.8: Model for effector and memory T cell differentiation and
dedifferentiation including genome integrity. N.b. the schematic above is an
elaboration of Figure 2.16; here, the parameter of genome integrity is considered. A
naïve T cell is activated by encounter with cognate antigen in the context of
immunological danger and gives rise to a clonal stem cell hierarchy marked by
increasing proliferation, progressive cytotoxic effector differentiation, and diminishing
genome integrity (underlying “power bars” in red and black; these refer to multiple
aspects of genome integrity, including telomere length, unresolved or misrepaired
double strand breaks, proliferation-induced point mutations, and putative activationinduced retrotransposon retro-integration events). Following antigen elimination and the
resolution of acute infection, terminally-differentiated effector cells (red) largely commit to
apoptosis, whereas intermediately effector-differentiated transient-amplifying / memory
precursor cells (green) gradually reacquire the stemness of their progenitors (blue). In
the post-antigen phase, the pool of memory T cells, composed of TSC and TSC’
populations, is heterogeneous with respect to proliferative past and history of effector
differentiation, and putatively as well in terms of genome integrity (which corresponds to
a multitude of potential parameters, including accumulated mutations, retrotransposion
reintegrations, single and double strand breaks, and telomere length).
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.:: CHAPTER 4 ::.
SIGNAL FLUX IN AND SIGNALING-DEPENDENT ABUNDANCE
OF T STEM CELLS; IMPLICATIONS FOR IMMUNOTHERAPY
4.1 Command and control: multifactorial regulation of T cell function
That T cells are equipped with tremendously potent effector mechanisms with the
potential to profoundly remodel organismal physiology is perhaps most saliently
manifest in recent reports of cancer immunotherapies, wherein therapeutic
manipulation of T cell function in human patients has been shown to precipitate
dramatic and durable remissions of even large or disseminated tumors in a highly
specific manner and with minimal off-target pathophysiology (Figure 4.1).
Conversely, the destructive potential of T cells is equally apparent, as evidenced
by the profound burden of suffering borne by those afflicted with autoimmune
disorders, many of which are T cell-dependent (Bluestone et al., 2010).
Accordingly, 500 million years of evolution since the dawn of adaptive immunity
have conspired to construct an elaborate apparatus regulating T cell functionality
such that these cells’ considerable physiological force maximally subserves
organismal fitness and minimizes the potential for mischief. An overarching
research aim for decades has been to decipher this regulatory regime, both to
better understand basic immunological phenomena as well to develop the ability
to rationally manipulate immune function for prophylactic and therapeutic ends.
A leading model to explain the regulation of lymphocyte function posits
that they integrate both positive and negative micro-environmental signals that as
a whole conduce to either activation (initial or continued) or inhibition. This
notion originated in the so-called “two signal” hypothesis (Bretscher and Cohn,
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1970; Lafferty et al., 1974) that was subsequently elaborated by Janeway and
Matzinger, and which held that in order to spring forth from dormancy into
concerted action, lymphocytes required not only recognition of their cognate
antigen, but also receipt of a second, “costimulatory” signal to provide contextual
information, such as whether the antigen in question was initially encountered in
a pathological or physiological scenario (e.g., respectively, a potentially
dangerous viral infection, or a foreign yet nevertheless innocuous food substance
in the gastrointestinal tract). Since then a variety of additional classes of signals
have been recognized that complexify the original model, such that not just two
but rather multiple external signals are sensed and interpreted by lymphocytes in
a manner that enables a nuanced, highly calibrated response to prevailing
environmental conditions (Smith-Garvin et al., 2009). The molecular nature of
these signals and their mechanisms of transduction has been elucidated in
increasing detail in recent years (Attanasio and Wherry, 2016). However, from a
cellular perspective, it remains very much unclear the extent to which any given
signal is sensed by and directs the function of the many subsets of lymphocytes
known to exist. For example, CD28 is a prominent receptor of costimulatory
signals that enhance TCR- (i.e., antigen) induced proliferation of T cells.
However, since its identification in the early 1980’s, it’s become clear that CD28
is not uniformly expressed on T cells. Instead, there can be a broad range of
expression on different T cell subsets, suggesting that signals transduced by
CD28 and a rapidly growing list of related molecules may differentially impact
cells depending on T cell subtype.
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Here, these matters are explored with respect to the CD62Lhi T stem cell
population whose isolation and initial characterization was detailed in previous
chapters. Therein, this rare population of cells was shown to be uniquely potent,
for example with respect to the capacity to generate legions of cytotoxic effector
cells. How is this power engaged, directed, and regulated? Data are presented
in this chapter indicating that T stem cells highly express a panoply of sensors for
multiple classes of signals, both activating and inhibitory. Far from being inert
with respect to signaling, as originally envisioned given their relative proliferative
quiescence, T stem cells instead appear to be remarkably sensitive to and
interconnected with their environments. Unexpectedly, this quantitatively minor
subset may in fact reside at an cellular signaling nexus that can powerfully initiate
immune responses de novo, or potentiate or terminate existing ones.

4.2 Anatomic localization of T stem cells
While environmental signals and the intracellular interpretation thereof are
important for all cells, they appear to be particularly pertinent for stem/progenitor
cells whose decisions regarding state and fate commitments impact not only
themselves but also many multitudes of downstream progeny cells and all the
various cells and tissues with which those cells interact. Moreover, perhaps due
to their unique requirements for life-long persistence and generative output, stem
cells rely considerably on external inputs from neighboring cells, for example in
terms of signals and nutrients that minimize cellular stress and promote survival
(Mendez-Ferrer et al., 2010). This notion that stem cells function not strictly
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autonomously in an amorphous void but rather exist in and depend upon a
biologically-defined niche was originally proposed in an attempt to explain
discrepancies between predicted and observed behavior in hematopoietic stem
cells isolated from different anatomic locations (Schofield, 1978). Decades later,
demonstration and cellular delineation of stem cell niches – first in Drosophila
ovaries (Xie and Spradling, 2000) and subsequently in multiple rodent tissues
(Lander et al., 2012) – substantiated this hypothesis and cemented the modern
concept that niches are micro-environments with specific compositions of
supporting cell types, hormones, nutrients, mechanical forces, and gas tensions
(Simon and Keith, 2008; Mendez-Ferrer et al., 2010; Sun et al., 2012). Together,
this surrounding ensemble sustains stem cell populations and helps modulate
their delicate balance between self-renewal and terminal differentiation.
Therefore, understanding stemness includes but extends well beyond merely
isolating and studying stem cells themselves. In short, anatomy matters.
To begin to understand the environmental circumstances in which T stem
cells exist and that might bear on understanding mechanisms by which they are
regulated, a gross anatomical survey of the abundance of CD62Lhi T stem cells
was undertaken. The CD62Lhi population was rare but evident in all tissues
examined 8 days pi with LCMV, and present at the highest frequency in lymph
nodes (Figure 4.2A). Beyond gross anatomy, the micro-anatomical residence of
the three virus-specific CD8+ T cells subsets was analyzed in the spleen using
intravascular antibody labeling, a technique that indicates localization in the
blood-accessible splenic red pulp relative to the blood-inaccessible, lymphoid
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white pulp (Galkina et al., 2005; Anderson et al. 2014). Evident was a clear a
hierarchy of labeling (Figure 4.2B). As a reference point, naïve CD8+ T cells
exhibited the lowest extent of intravascular labeling, reflecting the known
residence of these cells in the white pulp (Figure 4.2B). The two CD62Llo
effector CD8+ T cell subsets were highly labeled, indicating homing to the red
pulp and consistent with previous observations (Jung et al., 2010; Seo et al.,
2016). In contrast, the CD62Lhi subset exhibited intermediate intravascular
antibody labeling, indicating preferential localization to the lymphoid white pulp
among the three antigen-specific CD8+ T cell subsets (Figure 4.2B). This is
consistent with the preferential lymph node localization of the CD62Lhi subset
(Figure 4.2A), and suggests the possibility that effector and memory CD8+ T cell
differentiation might correlate with anatomical positioning. Indeed, recent studies
have indicated that T cells localized to the white pulp during the expansion phase
have greater potential to contribute to immunological memory than those in the
red pulp (Seo et al., 2016). Moreover, these gross- and micro-anatomical
patterns of lymphoid-biased residence evident in the CD62Lhi subset were
paralleled by pronounced expression of CXCR3 and CXCR5 (Figure 4.3),
localization molecules associated with memory and progenitor T cell biology,
respectively (Sung et al., 2012; Im et al., 2016). Simultaneously, the CD62Lhi
subset exhibited very low expression of CX3CR1 (Figure 4.3), a localization
factor associated with effector T cell differentiation (Gerlach et al., 2016). The
CD62Lhi subset also highly expressed CD69 (Figure 4.3), a molecule that
strongly promotes lymphoid localization (Mackay et al., 2015), together with
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CXCR5. Thus, the expansion phase CD62Lhi subset resides preferentially in
specific gross- and micro-anatomical regions, namely those with lymphoid
character. Coincidentally, this geography is matched by expression of molecules
that drive lymphoid homing. Together, these anatomical and molecular features
distinguish the CD62Lhi T stem cell subset from the two CD62Llo subsets as well
as from precursor naïve T cells, and suggest that it is distributed not randomly
but instead in a defined niche. This is likely to be important for committing to and
sustaining memory and progenitor fate decisions.

4.3 T stem cells’ TCR signaling flux and sensory apparatus
That T stem cells exhibited unique patterns of both localization (Figure 4.2) and
proliferation (Figure 2.8) suggested possible differences in signal reception
and/or transduction. To assess whether CD62Lhi T stem cells exhibited evidence
of differential stimulation during the expansion phase relative to the other
subsets, Nur77-GFP reporter mice were exploited. In this construct, GFP
expression reflects recent TCR stimulation (Moran et al., 2011). GFP expression
was readily apparent, yet similar, in the two LCMV-specific CD62Llo effector
CD8+ T cell subsets at d5 pi (Figure 4.4). In contrast, CD62Lhi T stem cells
expressed considerably higher GFP than either of the two CD62Llo subsets,
suggesting stronger and/or more recent TCR signal transduction (Figure 4.4). In
point of fact, this indication of stronger stimulation was reflected in elevated
expression on the CD62Lhi subset of CD3 and CD8 (Figure 4.5), essential
elements of the TCR signal transduction complex. This was also the case for
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CD28 (Figure 4.6), the stereotypical immunoglobulin (Ig) superfamily receptor for
costimulatory signals that plays critical roles in both the initiation of T cell
responses as well as in the therapeutic potentiation thereof in the context of
immunotherapies for cancers and chronic viral infections (Hui et al., 2017;
Kamphorst et al., 2017). The preferential expression by CD62Lhi cells of CD28
was matched by a similar pattern of expression of a bevy of additional
costimulatory receptors, including CD27, ICOS, and GITR (Figure 4.6). What is
more, CD62Lhi cells also robustly expressed receptors for multiple additional
classes of stimulatory signals, including those denoting inflammatory state (aka
signal 3, Figure 4.7) and licensing help from kindred lymphocyte populations
(e.g. CD4+ T cells and/or B cells; Figure 4.8). Together, these observations
indicate that T stem cells, relative to their downstream CD62Llo progeny, are both
exceptionally sensitive to their environmental surroundings and also robustly
transduce signals therefrom.
The simultaneous observations of heightened receptivity to stimulatory
signals in tandem with elevated expression of the downstream Nur77
transcription factor appeared paradoxical given the relatively attenuated
proliferation of the CD62Lhi subset (Figure 2.8A-C). Recent studies have
demonstrated that expansion-phase CD8+ T cells in the white pulp exhibit lower
two-dimensional effective affinity relative to CD8+ T cells in the red pulp (Seo et
al., 2016). The CD62Lhi T stem cell subset was enriched in the white pulp, but
appeared to receive stronger stimulation, rather than the weaker stimulation that
would be predicted based on lower effective affinity unless these cells possessed
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a mechanism to limit the effects of TCR stimulation. One way by which T cells
modulate their sensitivity to antigen signaling is by deploying expression of
inhibitory receptors that attenuate stimulatory signals. For example, one
prominent such receptor is CTLA-4, first established as a negative regulator of T
cell function more than two decades ago (Walunas et al., 1994; Krummel and
Alison, 1995). CTLA-4, absent on naïve T cells, is rapidly expressed on the
surface of T cells following activation and is upregulated by ligation of CD28.
Engagement of CTLA-4 can dampen the amplitude of T cell responses by
disrupting AKT signaling and/or by outcompeting CD28 for its activating ligands,
in either case restraining costimulation and overall T cell functionality (Parry et
al., 2005). The essentiality of this restraint in maintaining self-tolerance and
limiting collateral tissue damage during immune responses is manifest in the
severe autoimmunity induced by pharmacological blockade of CTLA-4 in the
context of human anti-cancer immunotherapies, and in the lymphoproliferation
and lethal, multiorgan immunopathology that rapidly emerge in mice genetically
deficient for CTLA-4 (Tivol et al., 1995).
Given that CD62Lhi cells exhibit such a strongly activated phenotype, and
since CTLA-4 is such an important regulator of T cell function, its expression was
evaluated during the expansion phase of viral infection. A hierarchy of expression
existed in LCMV-specific CD8+ T cell subsets: interestingly, the CD62Lhi subset
expressed the highest amount of CTLA-4, whereas progressive effector
differentiation in the two CD62Llo subsets was associated with lower CTLA-4
abundance (Figure 4.9). This pattern of expression was evident for multiple
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additional inhibitory receptors, including PD-1 and LAG-3, which act as rheostats
to tune antigen-responsiveness in peripheral tissues (Okazaki et al., 2013;
Honda et al., 2014), and CD5, an additional negative regulator of T cell signaling
whose expression has been shown to be proportional to TCR signaling strength,
at least in the thymus (Azzam et al. 1998) (Figure 4.9).
The elevated expression of PD-1 on the CD62Lhi subset was particularly
remarkable, given the rich biological and clinical context in which this molecule is
situated. A member of the CD28 Ig receptor superfamily, PD-1 shares a number
of inhibitory features with CTLA-4, yet differs from it in several structural and
mechanistic respects (Parry et al., 2005). Functionally, PD-1 attenuates T cell
function both by antagonizing TCR signaling (Okazaki et al., 2013) and by
disrupting CD28-mediated costimulatory signals (Hui et al., 2017, Kamphorst et
al., 2017). PD-1 is expressed primarily on leukocyte populations, while its ligand
PD-L1 can be upregulated by IFNγ signaling in multiple cellular lineages,
including both hematopoietic and epithelial cells. Notably, pharmacological
blockade of the PD-L1—PD-1 signaling axis can dramatically potentiate
suppressed T cell responses to persisting pathogens in the context of chronic
microbial infections (Barber et al., 2006) and cancers (Topalian et al., 2015).
Intriguingly, when PD-L1 expression was measured in subsets of antigenspecific CD8+ T cells during the expansion phase of viral infection, a pattern
similar to that of PD-1 was detected (Figure 4.10A). Specifically, among antigenexperienced T cells, the CD62Lhi subset expressed the greatest amount of PD115

L1, whereas PD-L1 expression was diminished in CD62Llo subsets. When the
CD62Lhi population was itself subsetted based on its heterogeneous expression
of PD-1 (Figure 4.9), higher PD-L1 expression was observed on the
subpopulation of CD62Lhi cells that expressed more PD-1, indicating that both
the PD-1 inhibitory receptor and its ligand are simultaneously expressed by
CD62Lhi T stem cells (Figure 4.10B).
In summary, attenuated proliferation during the expansion phase and
constrained effector differentiation of the CD62Lhi subset despite elevated TCR
signaling (as evidenced by Nur77 expression) and activation status (expression
of CD69, as well as additional markers such as CD11a and CD38 – cf. Figure
2.5) is associated with heightened expression of a constellation of inhibitory
receptors known to restrain T cell activation and terminal differentiation. In at
least one instance, this robust inhibitory receptor expression is paralleled by
similarly pronounced expression of its own ligand, underscoring the depths to
which inhibition and restraint may be fundamentally important themes in the lives
of CD62Lhi T stem cells.

4.4 Sensitivity to Strength of Stimulus
Given the multiple indications that CD62Lhi T stem cells appeared to be a focal
point for the sensing of environmental cues, it was important to explore this
notion further and ask whether varying the strength of signaling inputs might
have functional consequences. For example, at least at the level of bulk (i.e.
unsubsetted) antigen-specific CD8+ T cell populations, it has been established
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that strength of TCR signaling impacts the balance of effector vs. memory fate
commitment decisions (Marzo et al., 2005; Sarkar et al., 2007; Sarkar et al.,
2008). Thus it was of interest to ask whether the abundance of the CD62Lhi
subset varied in populations of endogenous, epitope-specific CD8+ T cell
populations that are known to receive different amounts of stimulation (Sarkar et
al., 2007). Consistent with the notion that subdominant responses receive less
stimulation, a higher frequency of the CD62Lhi subset was evident in the
subdominant GP276-specific response compared to the more dominant GP33- or
NP396-specific responses (Figure 4.11A). To examine the relationship between
the CD62Lhi subset and strength of TCR stimulation in more detail, graded doses
of naïve P14 CD8+ T cells were transplanted into naïve recipient mice, and these
chimaeras were then infected with LCMV. Supra-physiological numbers of TCRtransgenic CD8+ T cells are known to increase competition between responding
cells for stimulatory signals, thereby decreasing the average stimulation available
to any given T cell (Butz and Bevan, 1998; Marzo et al., 2005). Indeed, with
increasing dose of transferred naïve P14 cells, a higher frequency of the CD62Lhi
subset was observed at d8 pi (Figure 4.11B), consistent with previous studies
(Wherry et al., 2003; Marzo et al., 2005; Sarkar et al., 2007). This pattern was
paralleled by increased expression of CD62L itself within CD62Lhi cells (Figure
4.11B), as well as decreased expression within the overall antigen-specific P14
“tissue” of the effector-differentiation-promoting transcription factor Blimp-1
(Figure 4.11C). Additionally, the enhanced emergence of the CD62Lhi subset in
the context of attenuated strength of stimulation also corresponded to an
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increase in the frequency of cells that had proliferated to a lesser extent, as
indicated by incomplete CTV dilution (Figures 2.8A, bottom, and 2.8B, right).
Thus, CD62Lhi T stem cells are characterized by superlative signal flux, and this
matters functionally: attenuated strength of external antigen signals impacted the
proliferation and differentiation state of CD62Lhi cells, and increased their
frequency amongst total populations of epitope-specific CD8+ T cells.

4.5 Compromise of T stem cell compartment consequent to genetic
deficiency of inhibitory receptors
Given that attenuating signal strength potentiated T stem cells, it was of interest
to determine whether intensifying signal strength might have the opposite effect.
That unperturbed T stem cells naturally experience high signal flux (Figure 4.4)
even while robustly expressing a formidable array of signal-attenuating factors
(Figures 4.9 and 4.10) renders this question particularly salient – could
increased strength of signaling deleteriously impact T stem cells? To address
this possibility, P14 CD8+ T cells were generated to be genetically deficient for
the inhibitory receptor PD-1. Naïve WT and PD-1-deficient P14 cells were mixed
together in a 1:1 ratio and co-transplanted into recipient mice, and these
chimaeras were subsequently exposed to viruses that generate acutely-resolving
infections (Figure 4.12A). In the settings of Flu and LCMV-Armstrong infections
administered intranasally, the splenic PD-1-deficient CD62Lhi T stem cell
population was diminished at d8 pi, consistent with the hypothesis; however, this
phenotype was not observed following intraperitoneal infection with LCMVArmstrong (data not shown). Though the explanation for the dependence of the
118

phenotype upon route of infection is unclear, intranasal but not intraperitoneal
infection can engender presentation of processed viral antigen that persists for
months after replication-competent virus has been cleared, resulting in longlasting T cell stimulation (Zammit et al., 2006; Takamura et al., 2010). These
considerations are consistent with the notion that signal strength may be toxic to
T stem cells above a certain threshold, and that this threshold was exceeded by
the overall integration of the strength and duration of signaling in intranasally- but
not intraperitoneally-initiated infections. To probe this hypothesis, a strategy was
devised to further intensify signal strength within the context of an
intraperitoneally-initiated infection by ablating expression of an additional signalattenuating factor. Accordingly, P14 CD8+ T cells were generated to be
simultaneously deficient for PD-1 and LAG-3, a CD4-homologous inhibitory
receptor with a known role in restraining the proliferation of activated T cells
during viral infections, both per se (Workman et al., 2004) and in synergistic
cooperation with PD-1 (Blackburn et al., 2009). Hence, the aforementioned
experiment was repeated using doubly-IR-deficient P14 cells and LCMV infection
initiated via the intraperitoneal route. In this setting, doubly-IR-deficient CD8+ T
cells expanded to a greater extent than did WT cells; however, the IR-deficient
CD62Lhi T stem cell compartment was markedly diminished (Figure 4.12B).
Thus, T stem cells appear to be programmatically equipped to sense and
transduce strong environmental signals, including at the high levels that attend
the mitotic maelstrom of the expansion phase of microbial infections. However,
intensifying the strength of this signaling eventually overwhelms the buffering
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mechanisms that T stem cells deploy to maintain a careful balance between selfrenewal, terminal differentiation, and death: in the absence of a single inhibitory
receptor – PD-1 – T stem cell viability is compromised in some (intranasallyintroduced infections) but not all scenarios. When signal attenuation capacity is
further undermined by combined inhibitory receptor deficiency, T stem cells
appear invariably diminished.

4.6 Conclusions and Future Directions
By way of heightened expression of multiple classes of signal receptors, and to a
greater extent than other subsets, CD62Lhi T stem cells were observed to be
highly sensitive to environmental cues. The full import of this observation
remains undefined; however, given CD62Lhi cells’ role as progenitors that spawn
abundant downstream progeny upon demand, exquisite environmental sensitivity
on the part of these cells makes sense in terms of carefully calibrating T
lymphopoietic output with organismal requirements. I.e., to either activate or
amplify, or alternatively to attenuate or terminate T cell responses to pathogenic
perturbations, it is not difficult to envision multiple signals conveying either peril
or calm efficiently converging on T stem cells, which in turn respond by
escalating or diminishing proliferative output.
In the studies herein, the expression of a broad range of signal receptors
(and various regulators thereof) has been measured. Future work should
undertake a comprehensive transcriptomic and proteomic survey to grasp the full
breadth of T stem cells’ signaling sensitivity. This is important for both basic
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understanding of T cell immunobiology, as well as for the design of
immunomodulatory therapeutics and prophylactics. For example, T stem cells
robustly express the receptor for IL-18, a a potent proinflammatory cytokine.
Leukocytes and other cells utilize multiple additional factors to signal
inflammatory status, including IL-12, ΙFNα, and IFNγ. Do T stem cells express the
apparatus necessary to sense and interpret these signals? If so, how do each of
these cells influence T stem cell fate and state, especially with respect to
balancing proliferation versus quiescence, or self-renewal versus differentiation?
Of note, T stem cells robustly express Sca-1 (Figure 2.5), which is known to play
an important role in the transduction of IFNα signaling (Essers et al., 2009).
Furthermore, hematopoietic stem cells, from which T stem cells ultimately derive,
and with which they very likely overlap transcriptionally (Luckey et al., 2006; Im et
al., 2016), are highly sensitive to both IFNα and IFNg and modulate their
proliferative output in response to those signals (Essers et al., 2009; Baldrige et
al., 2010). Additional signals known to be important in shaping memory and
effector T cell fate commitment decisions include the anti-inflammatory molecule
IL-10 (Laidlaw et al., 2015) and the alarmin IL-33 (Bonilla et al., 2012). It is likely
that T stem cells express receptors for these signals, perhaps quite robustly; this
possibility should be empirically determined.
Beyond local agents, organism-wide parameters and behaviors have been
associated with various immunological outcomes of interest, and separately with
specific signaling events. For example, emerging evidence suggests that
moderate (but not exhaustive) exercise can enhance responsiveness to
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vaccination against a variety of viral pathogens, including varicella zoster virus
(Irwin et al., 2007) and influenza (Kohut et al., 2004; Hallam and Kohut 2013.
Intriguingly, musculature has recently been appreciated as a facultative
endocrine tissue that – exclusively in the context of physical exertion – secretes a
variety of hormones (called “myokines”) that can potently remodel organismal
physiology (Rao et al., 2014; Schnyder and Handschin, 2015). It is worth noting
that one such myokine is IL-15 (Rinnov et al., 2015); that IL-15 is critical for the
homeostatic proliferation and long-term maintenance of CD8+ T cell memory
(Goldrath et al., 2002); and furthermore that CD62Lhi T stem cells very highly
express CD122 (Figure 2.5), a key component of the IL-15 receptor complex.
Future work should empirically probe whether these coincidences arise from
mechanistic intersections. Overall, given the desirability of understanding the
interplay between unfolding adaptive immune responses and both proximal and
broader environmental cues, and of enhancing immune responses to both
prophylactic and therapeutic modulations, it will be important to achieve a
comprehensive grasp of the signaling sensitivity of T stem cells.
Irrespective of breath of environmental sensitivity, it is readily apparent
that CD62Lhi T stem cells are acutely responsive to external signals. They may
therefore deploy inhibitory receptors to prevent over-stimulation and consequent
depletion (via excessive terminal differentiation and/or death). This notion is
borne out in the compromised T stem cell compartment that is observed in the
genetic absence of inhibitory receptors. The longer-term functional implications
of this result for immunological memory formation remain to be established;
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however, given that stem cells are essential for long-term tissue homeostasis,
especially in the context of constitutive or on-demand rapid turnover (cf. Chapter
1), it is challenging to envision constructive outcomes with respect to overall
organismal homeostasis and immunocompetence. What is more, clinical anticancer treatment strategies are currently being contemplated or developed that
entail permanent incapacitation of PD-1 function, and/or transient suppression of
not just one but multiple signal-attenuation factors in T cells (Wolchock et al.,
2013; Liu et al., 2015; Nolan et al., 2017). These efforts may conceivably
conduce to control of tumors refractory to other treatment modalities and are
worthy of consideration; however, the possibilities of T stem cell toxicity and likely
consequent accelerated immunosenescence and immunodeficiency must not be
discounted, and should be carefully monitored and weighted in the strategic costbenefit calculus. This is important both for the treatment of primary tumors, and
for engendering the immunological memory that may be necessary to prevent
future cancer recurrence.
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Figure 4.1

2005

2010

Figure 4.1: Proof-of-principle of curative immunotherapy for advanced cancer. A
patient was treated with immunotherapy for a bulky, ulcerating, metastatic tumor. The
therapy elicited a complete regression that endured for at least five years. Reproduced
with permission from: Crompton JG, Sukumar M, and Restifo NP. Uncoupling T cell
expansion from effector differentiation in cell-based immunotherapy. Immunol
Rev. 2014 Jan; 257(1):264-76.
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Figure 4.2
d8-Arm: Frequency of Tcm in Ag-Specific Population by Tissue
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Figure 4.2: Gross- and micro-anatomical analysis reveals preferential lymphoid
localization of antigen-specific CD62Lhi T stem cells during the CD8+ T cell
expansion phase of viral infection. A) Frequency of the CD62Lhi subset of CD8+ T
cells (among total P14 cells) in various tissues at d8 pi LCMV-Armstrong. B)
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Figure 4.4

Nurr77GFP Reporter: Elevated TCR Signaling in TSC during LCMV-Arm Infection
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Figure 4.4: Expression of the signal-strength reporter Nur77GFP in subsets of
antigen-specific CD8+ T cells. P14 CD8+ T cells transgenic for a GFP reporter of the
TCR-signaling strength-responsive locus Nur77 were transplanted into naïve recipient
mice. Following infection with LCMV-Armstrong, subsets of P14 splenocytes were flowcytometrically evaluated for GFP expression at d5 pi.
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Figure 4.5
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Figure 4.7
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Figure 4.8

Ag-Specific & Polyclonal IL-21R Expression
Ag-Specific
& nsPolyclonal
* IL-21R Expression
500
*

ns

500

*

*

400

IL-21R
IL-21R
MFIMFI

IL-21R (MFI)

400

300
300

200
200

100

100

E

TE
T

MM
P

C
SCS

TT

TT

N Na
ai i
veve

0

P

0

CD8
CD8++GP33
GP33++

<PE-Cy5-A>:
<PE-Cy5-A>:IL-21R
IL-21R

IL-21R

+

polyclonalCD8
CD8+
polyclonal

blue = KLRG1lo CD127hi CD44hi CD62Lhi

hi
blue = KLRG1lo CD127
CD44hi CD62Lhi
red = KLRG1hi CD127lo CD44hi CD62Llo
red = KLRG1hi CD127lo CD44hi CD62Llo

Figure 4.8: Signal 4 -- Elevated expression of IL-21R on antigen-specific T stem
and progenitor cells during the expansion phase of the CD8+ T cell response to
viral infection. Subsets of GP33-specific
splenocytes were flow-cytometrically
polyclonal CD4+
+
evaluated at d8 pi LCMV-Armstrong
for
expression
of the IL-21 receptor. As an internal
polyclonal CD4
positive control, expression of IL-21R on B cells is depicted in the histogram overlaid in
IL-21R
yellow.
IL-21R
<PE-Cy5-A>: IL-21R

<PE-Cy5-A>: IL-21R

blue = CD127hi CD44hi CD62Lhi
lo

hi

lo

hi CD44
= CD127
CD62Lhi
bluered
= CD127
CD44hi CD62L
red = CD127lo CD44hi CD62Llo

<PE-Cy5-A>: IL-21R

<PE-Cy5-A>: IL-21R

GP33+ histogram overlays from mouse #2

note: yellow histograms = B cells

note: yellow histograms = B cells

GP33+ histogram overlays from mouse #2
d8 pi LCMV-Arm; spleen; n=5; gated on CD8+ GP33+

d8 pi LCMV-Arm; spleen; n=5; gated on CD8+ GP33+

131

Figure 4.9
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Figure 4.10
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Figure 4.11
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Figure 4.11: Attenuation of signaling strength diminishes antiviral CD8+ T cell
effector differentiation and augments T stem and progenitor cell abundance. A)
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.:: CHAPTER 5 ::.
PERSPECTIVE
5.1 Summation
In recent years substantial progress in basic understanding of adaptive immunity
has been matched by an explosion of popular interest in immunological science.
Serious infectious disease, once dismissed in industrially developed nations as a
mostly vanquished problem, has resurged following recent outbreaks of, to take
but two recent examples, measles and Ebola. The former has served to reintroduce a complacent public to the importance of vaccination (Foege, 2001;
Orenstein and Ahmdied, 2017), while the latter has underscored the enduring
urgency of further development in basic and applied vaccinology. Meanwhile,
after nearly a century of dormancy, the notion of harnessing the adaptive immune
system’s unparalleled potency and specificity to combat cancer is finally
beginning to flourish. Advances in cancer immunology are regularly reported in
the literature, and even given prominence in the popular press. Furthermore,
given the growing appreciation of the immune system as a critical, cell-extrinsic
tumor suppressor (Pawelec et al., 2009; Schreiber et al., 2011), interest is
emerging in potentiating adaptive immunity not only therapeutically against
established cancers but also prophylactically to prevent their occurrence — or
reoccurrence, following remission of primary cancers — in the first place.
Ultimate success in all of these avenues of inquiry — both prophylactic
and therapeutic manipulation of immunity to counter infection as well as
malignancy — depends upon the generation of memory lymphocytes, which can
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simultaneously initiate novel immune responses against re-encountered antigens
(e.g. in the context of pathogens or tumors) while maintaining the capacity to
spawn additional or sustain long-persisting immune responses upon subsequent
encounters.
However, despite decades of research and notwithstanding recent major
advances in the field, understanding of the developmental origins of memory
lymphocytes has remained confounded by dramatically conflicting literatures and
glaring gaps in knowledge (Ahmed et al., 2009; Restifo and Gattinoni, 2013).
Empirically, it is straightforward to start with an antigenically
inexperienced vertebrate animal, immunize it with it with a defined antigen and a
strong adjuvant, and be able to readily identify and isolate memory lymphocytes
several weeks later. However, the process of transformation from a naive,
transient lymphocyte into a durable, functionally robust memory lymphocyte is
largely a black box. What signals and imprints define and potentiate this
process? From what developmental origins do memory lymphocytes issue, and
when and where during the awesomely complex dynamics of adaptive immune
responses do they emerge?
In particular, ever since the seminal publication late last century of an
initial developmental structure of memory lymphopoiesis (Sallusto et al., 1999), a
fundamental question has concerned the potential existence of lymphocyte stem
cells. Given that adaptive immune responses by their very nature entail
prodigious proliferation causing the generation and regeneration of lymphocytic
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tissue, thinkers in the field noted early on the strong parallels of this process to
stem cell-mediated physiology in other tissues with rapid tissue turnover kinetics
such as blood, epidermis, intestinal epithelium and sperm (Fearon et al., 2001;
Lanzavecchia and Sallusto, 2002; Luckey et al., 2006). If stem cells therein are
ultimately responsible for the generation and continual regeneration of mature
erythrocytes, epithelial cells, et cetera, might a hypothetically equally rare and
equally potent lymphocyte stem cell mediate similar functions in the adaptive
immune compartment, and perhaps represent the long-sought root origin of
memory lymphocytes? If so, could understanding the nature of these agents of
regeneration enrich our understanding of both physiology and pathology, and
offer novel opportunities for prophylactic and therapeutic interventions?
These considerations have animated the research presented here from its
inception, and have culminated in the following findings:
1. Developmental dynamics of anti-pathogen T cell proliferation: A
classical proliferative hierarchy rooted in a rare yet potent stem cell
population drives anti-pathogen CD8+ T lymphopoiesis.
2. Elucidation of extraordinary developmental plasticity in T
lymphopoiesis: A salvage pathway of Teffector to Tmemory cell dedifferentiation
maximizes proliferative reserve available for future immunity and reveals
dual cellular pathways to immunological memory.
3. A new frontier of T cell retrotransposition dynamics: T cell activation
triggers reawakening of an ancient DNA parasite, with implications for an
irreversible molecular clock embedded in T stem cells.
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4. Organismal and cellular perspectives on getting old: Effector T cell
differentiation as a microcosm of organismal aging, and a specialized role for
stem cells as guardians of genome integrity.
5. Insight into mechanisms of immunosenescence & immunotherapy:
Heightened expression of inhibitory receptors on and hyperactivation
sensitivity of T stem cells.

5.1.1 A classical proliferative hierarchy rooted in a rare yet potent stem cell
population drives anti-pathogen CD8+ T lymphopoiesis.
Antigen-driven T cell expansion is structured according to a classical proliferative
hierarchy entailing a linear differentiation pathway anchored in a rare yet potent
stem cell population that progressively gives rise to increasingly specialized
cytotoxic effector T cells. This finding greatly clarifies longstanding questions
concerning the developmental nature of danger-driven lymphopoiesis, and
provides an answer to the mystery of how antigen-specific effector T cells can be
generated with such tremendous dispatch and abundance while nevertheless
avoiding severe degradation of the underlying genome integrity needed to
preserve the clonal lineage. In short, following activation by encounter with
antigen coupled with danger signaling, T stem cells are ontogenetically set-aside
and programmatically endowed with a panoply of defense mechanisms and
genome-protective activities that in toto conduce to maintaining a vital reserve of
self-renewing generative capacity. This in turn underwrites immunocompetence
against future antigen encounters.
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5.1.2 A salvage pathway of Teffector to Tmemory cell dedifferentiation
maximizes proliferative reserve available for future immunity and reveals
dual cellular pathways to immunological memory.
Chapter 2 presented data indicating that intermediately-differentiated effector
CD8+ T cells, having arisen from T stem cells by way of antigen-driven
proliferation, can convert into self-renewing CD8+ T stem cells (also called
“central memory”) following the resolution of infection and the termination of
antigen signaling. This process of a cell reacquiring stemness characteristics
that it had lost consequent to differentiation is consistent with dedifferentiation, a
phenomenon well-known in amphibian biology but poorly understood in
mammalian development. Once thought impossible in higher organisms, pivotal
research in the 1990’s (Wilmut et al., 1997) and in the 2000’s (Takahashi and
Yamanaka, 2006) upended the traditional, Waddington-esque understanding of
unyielding epigenetic gravity by elucidating the existence and extraordinary
potential of mammalian dedifferentiation (e.g. organismal cloning and the in vitro
induction of developmental pluripotency in fully differentiated cells). Though
these initial achievements occurred exclusively in highly contrived, experimental
circumstances, they nevertheless fomented further inquiry and lead to
recognition by the Nobel Prize for Physiology or Medicine in 2012. More recent
findings have extended these groundbreaking observations in vivo, including
during the regeneration of spermatogenesis (Nakagawa et al., 2010) and
epithelial differentiation following injury (Takeda et al., 2011; Tata et al., 2013),
and in the pathological context of tumorigenesis (Krivtsov et al., 2006).
Nevertheless, to date there have not been any reports of physiological
dedifferentiation in the immuno-hematopoietic system.
140

Thus, the observation of potential physiological dedifferentiation in the
adaptive immune system is novel and may bear substantial implications for basic
principles in developmental biology, genome integrity maintenance and the
architecture of aging, and mechanisms of malignant transformation of non-stem
progenitor cells into cancer stem cells.

5.1.3 T cell activation triggers reawakening of an ancient DNA parasite, with
implications for an irreversible molecular clock embedded in T stem cells.
The coupled observations during memory and effector T cell differentiation of the
inversely correlated expression of the LINE-1 retrotransposon and one of its
principle restriction factors, Apobec3, may represent a new frontier in
immunology and developmental biology more generally. First discovered during
the dawn of modern eukaryotic whole genome study (Adams et al.,1980), L1
transposons for decades have often been considered genetic detritus whose
extensive repeat sequences principally served to confound early genome
sequencing efforts. Recently however, L1 transposons have emerged as major
players in physiology, pathology, aging, and evolution (Gorbunova et al., 2014) –
as foretold by Barbara McClintock’s trailblazing research on “jumping genes”
(McClintock, 1950). Retrotransposition into quasi-random locations throughout
the genome and can be substantially genotoxic, by way of either insertional
mutagenesis or the introduction of double strand breaks. Accordingly, cells have
evolved to expend considerable efforts to suppress L1 expression.
The data presented in Chapter 3 indicate that L1 repression is disrupted
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by antiviral T cell activation. L1 expression closely correlated with extent of
effector differentiation, with the greatest expression in terminally differentiated
effector cells, and the least in minimally differentiated CD62Lhi T stem cells. This
phenomenon may have several major implications, including:
-

L1 copy number may appreciably increase as a function of extent of
differentiation; conversely, overall genome integrity may diminish consequent
to L1-mediated insertional mutagenesis and/or double strand breaks.

-

Though T stem cells robustly express the L1 restriction factor Apobec3, a
modest level of L1 expression nevertheless escapes this putative
suppression. Thus, at a much slower rate – relative to differentiated effector
T cells – L1 copy number may increase in T stem cells, especially following
repeated rounds of activation and/or proliferation. Since T stem cells are selfrenewing and apparently long-lived, L1 abundance therein may represent an
irreversible molecular clock that can be measured in a variety of experimental
and possibly even clinical/diagnostic applications. It is worth noting that all
present molecular clocks (e.g. telomere length) are known to be reversible in
at least some cases, and may therefore be incompletely reliable.

-

A notable corollary of these notions is the possibility of ubiquitous genotypic
mosaicism in antigen-experienced T cells. That is, given activation-induced
L1 derepression and random retrotransposition, it is highly possible that every
single descendent of an activated progenitor T cell bears a unique genome
characterized by distinct L1 insertion sites.
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-

A further corollary is that shared and unique L1 insertion sites can be used to
reconstruct developmental phylogenies and thereby retrospectively delineate
lineage relationships in vivo, potentially in both model organism systems and
humans, and in the absence of transgenic manipulations that can confound
similar approaches that rely on genetic engineering or transduction with
exogenous retroviruses.

-

The research herein on effector and memory T cell differentiation has been
significantly informed by the rich literature of progenitor cell biology that has
matured since Charles Leblond’s pioneering research on mammalian tissue
turnover in vivo using tritiated thymidine (Leblond et al., 1959). In turn it may
be possible that the lessons concerning T stemness and the dynamics of
effector differentiation gained in this dissertation research can inform novel,
general principles in developmental biology. In particular, if differentiation of
effector T cells from a relatively quiescent, geno-protective T stem cell source
entails derepression of LINE-1 retrotransposons, it is reasonable to
hypothesize that a similar phenomenon might characterize classical
proliferative hierarchies in other tissues, for example those that subserve
ongoing hematopoiesis, epitheliogenesis, neurogenesis, and
spermatogenesis. Are terminally differentiated hematopoietic cells (e.g.
granulocytes), neurons, and epithelial cells characterized by the scars of
accrued L1 retrotransposition? Does L1 copy number slowly increase in other
stem cell populations in blood, gut, skin, brain, etc.?
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In addition to these implications, the phenomenon of L1 derepression
consequent to T cell activation prompts several questions, including:
-

Is LINE-1 re-expression related to – either casually or consequentially – the
substantial epigenetic remodeling entailed in the transitions from a quiescent
naïve lymphocyte through to a blasting, cytotoxic effector T cell? There are
some indications in the literature that this may be the case – for example,
iPSC reprogramming is known to precipitate retrotransposon derepression
(Klawitter et al., 2016), and epigenetic therapy of lung cancers (e.g. with
HDAC or DNMT inhibitors) has been reported to relax suppression of dormant
endogenous retroviruses in an interferon-dependent manner (Chiappinelli et
al., 2015). Given that genetic parasites comprise not just a fraction but rather
the majority of our genome (de Koning et al., 2011), a reshuffling of these
elements may be an inescapable intermediate in major and/or rapid
transformations of epigenetic states.

-

While L1 transposons comprise nearly a fifth of the genome, they are in fact a
minority of the total complement of endogenous replicating elements. This
prompts the question of whether other known DNA parasites (for example socalled Alu transposons, or endogenous retroviruses) also are derepressed by
T cell activation and effector differentiation, and if they might also pose a risk
of insertional mutagenesis.
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5.1.4 Effector T cell differentiation as a microcosm of organismal aging,
and a specialized role for stem cells as guardians of genome integrity.
While stem cells are commonly regarded as residing in an amorphous,
undifferentiated state, for some time thinkers have proposed that instead they
represent a highly specialized cell type that can efficiently conserve genome
integrity in order to retard malignant transformation or aging (Cairns, 1975;
Schofield, 1978). Nevertheless, evidentiary support for this fundamental
proposition in stem cell biology is remarkably limited. In this light, the data in
Chapters 2 and 3 substantially enrich this idea, revealing that multiple
independent pathways that can regulate genomic integrity are enriched in T stem
cells, and conversely, relatively suppressed in terminally differentiated effector
cells. These include:
§
§
§
§

telomerase activity
responsiveness to DNA damage via H2AX phosphorylation
expression of the endogenous retroelement restriction factor Apobec3
cell surface membrane efflux of environmental toxins via ABC transporters
These observations concerning geno-protective activities are

complemented by data on genome integrity itself. Specifically, comet assay
measurements indicated that chromatin integrity is significantly diminished in
terminally differentiated effector cells a week after initial activation of precursor
naïve T cells. This suggests the possibility that antiviral T cell differentiation may
represent a microcosm of organismal aging, which is also characterized – both
causally and consequentially – by accumulation of senescent cells and declining
genome integrity. That these processes which unfold over a lifespan occur in the
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context of infection within just a week is biologically interesting in its own right,
and additionally may offer opportunities for dissecting mechanisms of aging in a
tractable, short-term experimental system. For example, rapamycin was the first
drug discovered to increase mammalian lifespan (Harrison et al., 2009).
However, this advance came only by way of years-long, resource-intensive
experimentation. In contrast, during the critical first week of antiviral T cell
differentiation, in vivo treatment with rapamycin increases the abundance of
CD62Lhi T stem cells (Figure 2.9), and thereby putatively enhances the genome
integrity of the entire antigen-specific “tissue”. Anti-pathogen T cell differentiation
may thus be a useful context in which to rapidly screen various pharmacological
or other interventions for potential anti-aging effects.
5.1.5 Heightened expression of environmental signaling receptors on and
hyperactivation sensitivity of T stem cells
In the first decade of the 20th century Paul Ehrlich proposed the deeply
controversial idea that the immune system might play a central physiological role
not only in defense against infectious disease but also susceptibility to cancer
(Ehrlich, 1909). Despite promising early experimental and clinical explorations of
this concept by Ehrlich and Robert Koch in Europe and William Coley in New
York, further development of immunotherapy suffered from a feeble theoretical
framework and fell out of favor as the post-war vogues of radiotherapy and
chemotherapy captured medical attention to the exclusion of alternative
approaches. Half a century later, Lewis Thomas and Macfarlane Burnet reenergized the notion on firmer theoretical grounds (Thomas, 1959; Burnet, 1967),
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and Burnet helpfully coined the term “immunosurveillance”. Evidentiary support
trickled in for several decades and finally exploded in recent years as two
different immunotherapy modalities began generating dramatic clinical results,
including complete and durable regression of even disseminated, metastatic
tumors: autologous transplantation of T cells reprogrammed ex vivo, and
pharmacological blockade of inhibitory / checkpoint receptors.
Despite these gains, meaningful clinical response to immunotherapies is
achieved in only a minority of patients. Investigators globally are now focused on
understanding this heterogeneity in efficacy in order to realize the full potential of
Ehrlich’s century-old idea. In this vein, important observations have revealed that
the success of anti-tumor T cell transplantation therapy is a function of selfrenewal capacity (Gattinoni et al., 2005; Gattinoni et al., 2011). In parallel,
seminal research from multiple groups around the globe has shown that
expression of inhibitory receptors including PD-1 is a major impediment to antitumor T cell efficacy, and that pharmacological blockade of PD-1 signaling can
overcome this obstacle to unleash anti-tumor immunity (Wherry and Kurachi,
2015; Chen and Mellman, 2017).
Thus the central issues facing the field include the separate but related
matters of 1) unfettering and 2) sustaining T cell proliferation that can mediate
anti-tumor immunity. What is the nature of proliferative capacity in antigenspecific T cell populations, and how can it be maximized? What are the
mechanisms of inhibitory receptor blockade, particularly with respect to
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differential sensitivity of and impact upon subsets of antigen-specific T cells –
which in turn are endowed with differing self-renewal capacities?
The characterizations of T stem cell biology here offer substantial potential
to elucidate both of these intertwined issues. In particular, T stem cells are a
principal locus of proliferative reserve from which legions of effector T cells are
spawned. They exist at a nexus of intense environmental signaling and therefore
robustly express multiple inhibitory receptors, including PD-1, and at least in the
contexts so far examined, to an extent greater than other T cell subpopulations.
The data detailed in Chapter 4 suggests that prolonged stimulation of T stem
cells genetically lacking PD-1 braking function results in depletion of this
quantitatively minor yet physiologically central subpopulation, perhaps conducing
to accelerated immunosenescence. Both from the perspectives of maximizing
proliferative potential and avoiding immunosenescence, and understanding the
biology of inhibitory receptors like PD-1 and the mechanisms and consequences
of blockade thereof, further understanding of the nature of T stem cells will be
important.
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APPENDIX A: MATERIALS AND METHODS
Mice and infections
All animals were purchased from Jackson Laboratories or Charles River
Laboratories, or bred at the University of Pennsylvania (Philadelphia, PA).
Experiments were performed in accordance with protocols approved by the
University of Pennsylvania Institutional Animal Care and Use Committee. BACtransgenic Blimp-1-YFP reporter mice were from E. Meffre (Yale University, New
Haven, CT), Fucci reporter mice (Sakaue-Sawano et al., 2008) were from
Yongwon Choi (University of Pennsylvania, Philadelphia, PA). Mice deficient for
TCF-1, PD-1, and LAG-3 were gifts of Avinash Bhandoola (National Cancer
Institute, Bethesda, MD), Arlene Sharpe (Harvard Medical School, Boston, MA),
and Dario Vignali (University of Pittsburgh School of Medicine, Pittsburgh, PA),
respectively. Nur77GFP reporter mice and CD90.1+ mice were obtained from
Jackson Laboratories. Deficiency, reporter, and congenic alleles were all bred
on to a P14 TCR-transgenic (Pircher et al., 1989) C57Bl/6 background.
Mice were infected with 2 × 105 plaque-forming units (PFUs) of
lymphocytic choriomeningitis virus (LCMV) Armstrong strain intraperitoneally or
2-4 ×106 PFU LCMV clone 13 strain intravenously, as previously described
(Wherry et al., 2003). Viruses were grown and titered as previously described
(Wherry et al., 2003).
Adoptive transfers and lymphocyte isolation
At indicated days pi, spleens and lymph nodes were harvested from CD90.2+
donor mice. CD90.1+ P14 CD8+ T cells were negatively purified by way of
staining with biotinylated monoclonal antibodies (CD4 #RM4-5, CD19 #1D3,
CD90.2 #53-2.1, TER-119, NK1.1 # PK136, Ly-6G #1A8) followed by counterstaining with streptavidin-conjugated magnetic beads (EasySep Streptavidin
RapidSpheres, from STEMCELL Technologies of Vancouver, Canada) and
magnetic separation. Subsequently sorted cell populations were adoptively
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transferred intravenously into recipient mice. In some experiments, before
transfer cells were labeled with 10 μM of the proliferation tracking vital dye
CellTrace Violet (“CTV”, from Thermo Fisher Scientific of Waltham, MA) for 10
minutes in the dark at 24°C.
BrdU treatment and detection
Animals were treated with 2 mg of BrdU (Sigma-Aldrich of St. Louis, MO) i.p. 24
hours prior to tissue harvest and analysis. BrdU incorporation was assessed by
the BrdU Flow Kit per manufacturer’s instructions (BD Biosciences of Franklin
Lakes, NJ).
Flow cytometry
Cells were stained with LIVE/DEAD Fixable Dead Cell Stain (Thermo Fisher
Scientific) to discern cell viability. Surface staining was performed at 4° in the
dark for 45 minutes in RPMI-1640 medium supplemented with 5 mM HEPES.
Intracellular staining was performed using the Foxp3 / Transcription Factor
Staining Buffer Set (Affymetrix, of San Diego, CA) or Cytofix/Cytoperm reagents
(BD Biosciences) per manufacturer’s instructions. Monoclonal antibodies were
purchased from BD Biosciences; BioLegend of San Diego, CA; Affymetrix; Cell
Signaling Technology of Danvers, MA; EMD Millipore of Billerica, MA; and
SouthernBiotech of Birmingham, AL; and included: CD8α #53-6.7, CD8β
#YTS156.7.7, CD16/32 #93, CD27 #LG.7F9, CD43 #1B11, CD44 #IM7, CD45.1
#A20, CD62L #MEL-14, CD90.1 #OX-7, CCR7 #4B12, IL-7Rα #A7R34, PD-1
#RMP1-30, LAG-3 #C9B7W, CTLA-4 #UC10-4F10-11, CD5 #53-7.3, CXCR5
#L138D7, KLRG1 #2F1, CX3CR1 #SA011F11, IFN-γ #XMG1.2, TNF-α #MP6XT22, IL-2 #JES6-SH4, T-bet #4B10, Eomes #Dan11mag, TCF-1 #C63D9,
pSer139-H2AX #JBW301, Ki-67. For intracellular cytokine staining, single-cell
suspensions were pre-treated for 1 hour with 0.1 mM TAPI-2 (Jabbari and Harty,
2006) and then incubated for 5 hours at 37°C in the presence of brefeldin A (BD
Biosciences), with or without 1 µM GP33-41 peptide. MHC class I peptide
tetramers were made and used as described previously (Wherry et al., 2003).
150

Data were acquired on a LSR II Flow Cytometer (BD Biosciences) and analyzed
with FlowJo software (FlowJo LLC of Ashland, OR). Cell sorting was performed
using a FACSAria II (BD Biosciences).
Ex vivo irradiation and pSer139-H2AX inducibility assay
Single cell suspensions of splenocytes were exposed to 0 or 250 rads of gamma
irradiation and incubated for 90 minutes at 37°C in RPMI supplemented with 10%
FBS. Cells were then stained for surface antigens and intracellular pSer139H2AX and acquired flow cytometrically.
Doxorubicin treatment
At the indicated time point post infection, mice were treated intravenously with
PBS or doxorubicin at 8 mg/kg or 16 mg/kg.
Comet assay
The alkaline comet assay was performed as described (Olive and Banáth, 2006),
with minor modifications. Briefly, a single-cell suspension of splenocytes was
embedded in molten agarose on CometSlides (Trevigen of Gaithersburg, MD)
and subjected to alkaline lysis for 1 hr. Following electrophoresis cells were
stained with ethidium bromide and 100-300 cells per slide were imaged
microscopically. Tail moments were evaluated using CASP software (Końca et
al., 2003).
Telomerase activity assay
The Telomeric Repeat Amplification protocol was performed as described
(Herbert et al., 2006). Heat-inactivated 293T cells were used as a negative
control.
Side population assay
The side population assay was performed as described (Lin and Goodell., 2006),
with minor adaptations. Briefly, a single cell suspension was stained with
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Hoechst 33342 and incubated for 90 minutes at 37°C. Cells were washed,
stained with surface antibodies and 7-AAD for viability discrimination at 4°C, and
finally resuspended and evaluated using an LSR II equipped with a 355 nm
ultraviolet laser.
Statistical Analysis
Student’s t test (paired and unpaired), and ANOVA tests were performed using
Prism software (Graphpad, La Jolla, CA). Asterisks indicate statistical
significance (p < 0.05). Error bars depict mean ± SEM.
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